Yayınlar & Eserler

Yayın Ağı
Makaleler 204
Tümü (204)
SCI-E, SSCI, AHCI (167)
SCI-E, SSCI, AHCI, ESCI (188)
ESCI (21)
Scopus (191)
TRDizin (42)
Diğer Yayınlar (5)

1. Early determinants of long-term outcomes in multiple sclerosis

Dörtkol O., Emekli A. S., Hacılar E., Öztürk Erden S., GÜNDÜZ T., KÜRTÜNCÜ M.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.107, 2026 (SCI-Expanded, Scopus) identifier identifier identifier

2. Long-term prognostic features of pediatric-onset multiple sclerosis: A large cohort from Türkiye.

Duman İlki C., Emekli A. S., GÜNDÜZ T., KÜRTÜNCÜ M., Eraksoy M.
Multiple sclerosis and related disorders , cilt.107, ss.107013, 2026 (SCI-Expanded, Scopus) identifier identifier identifier

3. Aquaporin-1 Antibodies in Autoimmune Inflammatory Demyelinating Disorders with Predominant Optic Nerve & Spinal Cord Involvement

Tüzün E., Karachalıou E., Pechlıvanıdou M., Tzanetakos D., Küçükali C. İ., Yılmaz V., et al.
Archives of Neuropsychiatry , cilt.63, sa.1, ss.375-379, 2026 (Hakemli Dergi) Creative Commons License

4. Cerebral tumefactive demyelinating lesions: clinical spectrum, long-term outcomes, and treatment

Kizek Ö., Emekli A. S., GÜNDÜZ T., KÜRTÜNCÜ M., Eraksoy M.
Acta Neurologica Belgica , cilt.126, sa.1, ss.109-121, 2026 (SCI-Expanded, Scopus) identifier identifier identifier

5. Letter to Editor: regarding the article “efficacy and safety of hematopoietic and mesenchymal stem cells in multiple sclerosis: a meta-analysis”

KÜRTÜNCÜ M.
Neurological Research , cilt.48, sa.4, ss.500-501, 2026 (SCI-Expanded, Scopus) identifier

6. Comorbid autoimmune diseases do not influence long-term disability progression in multiple sclerosis

Emekli A. S., GÜNDÜZ T., KÜRTÜNCÜ M.
Acta Neurologica Belgica , 2026 (SCI-Expanded, Scopus) identifier identifier identifier

7. Real-world effectiveness and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorder

KOÇ E. R., YETKİN M. F., SARIDAŞ F., Turan O. F., Sevim S., Terzi M., et al.
Journal of Neurology , cilt.273, sa.1, 2026 (SCI-Expanded, Scopus) identifier identifier identifier

8. Social Cognition in Multiple Sclerosis: A Multidomain Investigation

Akbalık D. E., KÜRTÜNCÜ M., GÜNDÜZ T., Bonato M.
Behavioural Neurology , cilt.2026, sa.1, 2026 (SCI-Expanded, Scopus) identifier identifier

9. Experiences of people with multiple sclerosis using clean ıntermittent catheterization: a qualitative study

POLAT DÜNYA C., ÖZKAN İ., Yalçın G. Y., GÜNDÜZ T., KÜRTÜNCÜ M.
DISABILITY AND REHABILITATION , 2025 (SCI-Expanded, SSCI, Scopus) identifier identifier identifier

10. Cross-cultural adaptation and psychometric validation of the Turkish version of Paper and Pencil Test in patients with multiple sclerosis

ÖZKAN İ., POLAT DÜNYA C., Yalcin G. Y., ÖZTÜRK ERDEN S., KÜRTÜNCÜ M.
NEUROLOGY ASIA , cilt.30, sa.4, ss.1179-1187, 2025 (SCI-Expanded, Scopus) identifier

11. Effect of a nurse-led online patient support program on fatigue, sleep and quality of life in patients with multiple sclerosis: a quasi-experimental study

Yalçın G. Y., TÜLEK Z., KÜRTÜNCÜ M.
BMC Neurology , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

12. Vaccination strategies in multiple sclerosis patients with Delphi methodology: A Turkish consensus

Cinar B. P., Tuncer A., ÇETİNKAYA L., Akbas O., Agalar C., Aluclu M. U., et al.
NEUROLOGY ASIA , cilt.30, sa.4, ss.1153-1168, 2025 (SCI-Expanded, Scopus) identifier

13. MOG and GFAP Antibodies are not Present in Headache with Neurological Deficits and Cerebrospinal Fluid Lymphocytosis (HaNDL)

Pechlivanidou M., Şanlı E., Kürtüncü M., Tzartos J., Tzartos S., Tüzün E.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.62, sa.4, ss.293-294, 2025 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

14. Transient tissue residency and lymphatic egress define human CD56bright NK cell homeostasis

Niehrs A., Hertwig L., Buggert M., Nordström I., Statzu M., Pampena M. B., et al.
Nature Immunology , cilt.26, sa.11, ss.2004-2015, 2025 (SCI-Expanded, Scopus) identifier identifier

15. Comparative efficacy of rituximab versus azathioprine in the treatment of MOG antibody-associated disease (MOGAD)

Şen S., KÜRTÜNCÜ M., Demir S., GÜNDÜZ T., Demirel E., TÜTÜNCÜ M., et al.
JOURNAL OF NEUROIMMUNOLOGY , cilt.407, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

16. Diagnostic Value of Serum Humanin-Like 3 Levels in Multiple Sclerosis Patients with Predominant Optic Nerve and Spinal Cord Involvement: A Preliminary Study.

Küçükali C. İ., Sancar N., Korkmaz H. Y., Gündüz T., Kürtüncü M., Tüzün E.
Noro psikiyatri arsivi , cilt.63, sa.1, ss.242-245, 2025 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier

17. Comparative analysis of five-year clinical outcomes of autologous hematopoietic stem cell transplantation and alemtuzumab in multiple sclerosis patients.

Manazoğlu H. C., İşkan G., Gündüz T., Emekli A. S., Akman G., Altunrende B., et al.
Multiple sclerosis and related disorders , cilt.100, ss.106542, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

18. Investigation of miR-335-5p and Its Target Gene C1QA Associated with the Complement System in Conversion from Clinically Isolated Syndrome to Multiple Sclerosis

Türk A., Küçükali C. İ., Köse T., Karaaslan Z., Kürtüncü M., Bayralı Ülker E., et al.
NOROPSIKIYATRI ARSIVI , 2025 (Scopus, TRDizin) identifier identifier

19. Real-world evidence from Türkiye on cancer risk and treatment exposure in multiple sclerosis: A histopathology-verified, registry-based study

Öztürk B., Taşkıran E., Demir S., ARAT M. M., Siva A., Ata N., et al.
Multiple Sclerosis and Related Disorders , cilt.100, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

20. Clinical characteristics and prognostic clinical factors of anti-gamma-aminobutyric acid-B receptor (GABAB-R) encephalitis in Türkiye: a multicenter study

Gozubatik-Celik R. G., Baykan B., Emekli A. S., Tuzun E., Soysal A., Uzunkopru C., et al.
NEUROLOGICAL RESEARCH , cilt.47, sa.7, ss.612-625, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

21. Clinical and Laboratory Characteristics of Patients with Neurosarcoidosis Nörosarkoidozlu Hastaların Klinik ve Laboratuvar Özellikleri

Emekli A. S., Gündüz T., Samanci B., Kürtüncü M.
Noropsikiyatri Arsivi , cilt.62, sa.2, ss.156-163, 2025 (SCI-Expanded, Scopus, TRDizin) identifier identifier

22. Prevalence and incidence of neuromyelitis optica spectrum disorder in Türkiye: A nationwide epidemiologic study

Taşkıran E., Öztürk B., Demir S., Ata N., Ülgü M. M., Birinci Ş., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.97, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

23. Exome sequencing reveals low-frequency and rare variant contributions to multiple sclerosis susceptibility in Turkish families

Büyükgöl F., GÜRDAMAR B., Aluçlu M. U., Beckmann Y., BİLGÜVAR K., BOZ C., et al.
Scientific reports , cilt.15, sa.1, ss.11682, 2025 (SCI-Expanded, Scopus) identifier identifier

24. Anti-JCV antibody index seroconversion in Turkish multiple sclerosis patients treated with natalizumab

Şahin E., GÜNDÜZ T., Emekli A. S., Ercanoğlu M., Erden S. Ö., KÜRTÜNCÜ M.
NEUROLOGICAL SCIENCES , cilt.46, sa.4, ss.1799-1805, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

25. Reply to letter: “On observing the standards of descriptive epidemiology: Comment on the article by Ozturk et al.” by author Koray Tascilar MD

Öztürk B., KÜRTÜNCÜ M.
Multiple Sclerosis Journal , cilt.31, sa.5, ss.621-623, 2025 (SCI-Expanded, Scopus) identifier

26. Letter to the Editor: Comments to “The magnetic resonance imaging (MRI) features of intracranial lesions in myelin oligodendrocyte glycoprotein-immunoglobulin G–associated disease (MOGAD)”

Manazoğlu H., KÜRTÜNCÜ M.
Clinical Radiology , cilt.83, 2025 (SCI-Expanded, Scopus) identifier identifier

27. Critical appraisal of patient selection methods in MS prevalence studies: Comment on the article by Lemmens et. al.

Ozturk B., KÜRTÜNCÜ M.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.94, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

28. Retinoic acid modulates peripheral blood helper innate lymphoid cell composition in vitro in patients with multiple sclerosis

Özkoşar A., Öktelik F. B., Gelmez M. Y., Öztürk Erden S., Gündüz T., Kürtüncü M., et al.
Journal of Neuroimmunology , cilt.398, 2025 (SCI-Expanded, Scopus) identifier identifier

29. Differentiating multiple sclerosis with predominant spinal cord and optic nerve involvement from other autoimmune demyelinating diseases using B cell immunophenotyping and gene expression profiling.

Yilmaz V., Karaaslan Z., Sanli E., Yuceer-Korkmaz H., Ulusoy C. A., Timirci-Kahraman Ö., et al.
Multiple sclerosis and related disorders , cilt.93, ss.106238, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

30. Redefining multiple sclerosis: 2024 McDonald diagnostic criteria

Manazoğlu H. C., KÜRTÜNCÜ M.
Turk Noroloji Dergisi , cilt.31, sa.3, ss.255-269, 2025 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier

31. The agreement between face-to-face and tele-assessment of balance tests in patients with multiple sclerosis

Erekdag A., Sener I. N., ZENGİN ALPÖZGEN A., GÜNDÜZ T., Eraksoy M., KÜRTÜNCÜ M.
Multiple Sclerosis and Related Disorders , cilt.90, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

32. Post-COVID-19 rhombencephalitis

KOÇ A., HUSEYNLI Z., GÜNDÜZ T., KÜRTÜNCÜ M.
Turkish Journal of Neurology , cilt.30, sa.3, ss.195-197, 2024 (TRDizin) Sürdürülebilir Kalkınma

33. Parenchymal Neuro-Behçet's disease or Comorbid Behçet's disease with multiple sclerosis: A discriminative analysis of a complex clinical entity

İsmayılov R., Talibov T., GÜNDÜZ T., KÜRTÜNCÜ M.
Multiple Sclerosis and Related Disorders , cilt.87, 2024 (SCI-Expanded, Scopus) identifier identifier

34. Neurological findings in patients with organic acidemias

Alıyeva G., Karakiraz A., Özdemir S., Durmuş A., Ak B., Kılıç Ş., et al.
European Journal of Neurology , cilt.31, sa.31, ss.12, 2024 (Düzenli olarak gerçekleştirilen hakemli kongrenin bildiri kitabı)

35. Prevalence and incidence of multiple sclerosis in Turkey: A nationwide epidemiologic study

Öztürk B., Taşkıran E., Demir S., TUNCER M. A., KÜRTÜNCÜ M., Karabudak R., et al.
Multiple Sclerosis Journal , cilt.30, sa.7, ss.790-799, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

36. Seronegative NMOSD patients display distinctive peripheral blood T-cell subset frequencies

Sanli E., Karaaslan Z., Yilmaz V., Gunduz T., Kurtuncu M., Turkoglu R., et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY , cilt.219, sa.1, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

37. Diffusion Tensor Imaging in Parenchymal Neuro-Behçet's Disease

Gündüz T., Server S., Küçükali C. İ., Özyurt O., Akman-Demir G., Kürtüncü M.
NOROPSIKIYATRI ARSIVI , cilt.61, sa.1, ss.39-46, 2024 (SCI-Expanded, Scopus, TRDizin)

38. Validity and Reliability of the Turkish Version of the Patient-Reported Impact of Spasticity Measure in Multiple Sclerosis

Yalçın G. Y., Dünya C. P., Yeni K., KÜRTÜNCÜ M., TÜLEK Z., GÜNDÜZ T., et al.
International Journal of MS Care , cilt.26, sa.Q3, ss.194-198, 2024 (Scopus) identifier identifier

39. [Cerebellar antibodies in post-stroke sera of acute ischemic stroke patients].

Atmaca M. M., Erdağ E., Demir S., Yüceer H., Atmaca M. Ç., Küçükali C. İ., et al.
Ideggyogyaszati szemle , cilt.76, sa.11-12, ss.394-398, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

40. Chloride intracellular channel protein-1 (CLIC1) antibody in multiple sclerosis patients with predominant optic nerve and spinal cord involvement

KARAASLAN Z., Şengül-Yediel B., Yüceer-Korkmaz H., ŞANLI E., GEZEN AK D., DURSUN E., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.78, 2023 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

41. mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity—Does it matter?

Tütüncü M., Demir S., Arslan G., Dinç Ö., Şen S., GÜNDÜZ T., et al.
Multiple Sclerosis and Related Disorders , cilt.75, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

42. Evaluation of Demographic, Clinical Characteristics and Side Effects in Multiple Sclerosis Patients Vaccinated Against SARS-CoV-2 Virus

Kizek Ö., Yalçın G. Y., GÜNDÜZ T., Kürtüncü M., Eraksoy M.
TURKISH JOURNAL OF NEUROLOGY , cilt.29, sa.2, ss.106-110, 2023 (ESCI) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

43. Serum IgG of patients with relapsing inflammatory optic neuropathy immunoreacts with Sox2-positive glial cells of the optic nerve

Erdağ E., Emekli A. S., Gündüz T., Küçükali C. İ., Kürtüncü M., Tüzün E.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.73, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

44. Examining The Effectiveness Of Two Different Web-Based Telerehabilitation Programs In People With Multiple Sclerosis

ZENGİNLER YAZGAN Y., Vural P., ERSÖZ HÜSEYİNSİNOĞLU B., TARAKCI E., İSENKUL M. E., Kurtuncu M.
MULTIPLE SCLEROSIS JOURNAL , ss.16, 2023 (SCI-Expanded, Scopus) identifier

45. The Effect of Smoking on Inactivated and mRNA Vaccine Responses Applied to Prevent COVİD-19 in Multiple Sclerosis

Şen S., Arslan G., Tütüncü M., Demir S., Dinç Ö., GÜNDÜZ T., et al.
Noropsikiyatri Arsivi , cilt.60, sa.3, ss.252-256, 2023 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier

46. Retrospective analysis of effectiveness of fingolimod in real life setting in Turkey (REFINE)

Tuncer A., Kürtüncü M., Terzi M., UYGUNOĞLU U., Göncüoğlu C., Yüceyar A. N., et al.
Turkish Journal of Medical Sciences , cilt.53, sa.1, ss.323-332, 2023 (SCI-Expanded, Scopus, TRDizin) identifier

47. Serum CXCL5 as a biomarker in multiple sclerosis and neuromyelitis optica spectrum disorder

KARAASLAN Z., YILMAZ V., YÜCEER H., ŞANLI E., Akcay H. I., Kurtuncu M., et al.
Northern Clinics of Istanbul , cilt.10, sa.3, ss.341-344, 2023 (ESCI, Scopus, TRDizin) Creative Commons License identifier identifier identifier identifier

48. Lesion probability map in cerebral vein thrombosis due to Behcet's disease

Emekli A. S., Dogan F. U., Gunduz T., Sezgin M., Ekizoglu E., Yesilot N., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.26, sa.1, ss.145-150, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

49. Evaluation of the Relationship Between Socio-demographic Characteristics and Social Support with Adherence to Treatment in Patient with Multiple Sclerosis

Yalçin G. Y., Beşer A., KÜRTÜNCÜ M.
International Journal of Disabilities Sports and Health Sciences , cilt.5, sa.2, ss.75-82, 2022 (Scopus) Creative Commons License identifier

50. Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios

Oezguen N., Yılmaz V., Horvath T. D., Akbayir E., Haidacher S. J., Hoch K. M., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.68, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

51. Recurrent intracerebral hemorrhage due to alemtuzumab treatment in a patient with multiple sclerosis: case report

Inci M., GÜNDÜZ T., Kurtuncu M., Eraksoy M.
ACTA NEUROLOGICA BELGICA , cilt.122, sa.5, ss.1389-1391, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

52. Evaluation of Clinical and Radiological Characteristics of TDLs, Long-Term Follow-up Results

KİZEK Ö., GÜNDÜZ T., KÜRTÜNCÜ M., ERAKSOY M.
EUROPEAN JOURNAL OF NEUROLOGY , ss.470-471, 2022 (SCI-Expanded, Scopus) identifier

53. Acanthamoeba encephalitis in an immunocompetent patient: A case report

Bugdayci Z., Kizek O., Yildizhan H., Gunduz T., Bilgic M., Boral O., et al.
EUROPEAN JOURNAL OF NEUROLOGY , ss.743, 2022 (SCI-Expanded, Scopus) identifier

54. Dimethyl Fumarate in Multiple Sclerosis Patients: A Real World Study

GÜNDÜZ T., ÖZTÜRK ERDEN S., ERAKSOY M., KÜRTÜNCÜ M.
Kocaeli Üniversitesi Sağlık Bilimleri Dergisi , cilt.8, sa.2, ss.129-133, 2022 (Hakemli Dergi) identifier

55. Comparison of Mitoxantrone versus Cyclophosphamide Treatment in Patients with Secondary Progressive Multiple Sclerosis

GÜNDÜZ T., ÖZCAN G., ÇAKAR A., AKÇAY H. İ., ÖZDAĞ ACARLI A. N., ERAKSOY M., et al.
Dicle Tıp Dergisi , cilt.49, sa.1, ss.29-35, 2022 (TRDizin) identifier

56. Lesion Distribution Pattern of Parenchymal Neuro-Behcet's Disease Using Probability Mapping

Emekli A. S., Ersozlu E., Emekli M. A., Gunduz T., Kurtuncu M.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

57. CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients

KARAASLAN Z., KÜRTÜNCÜ M., Akcay H. I., GÜNDÜZ T., Altunrende B., Turkoglu R., et al.
EUROPEAN NEUROLOGY , cilt.85, sa.1, ss.69-71, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

58. The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?

Sen S., Tuncer A., ÖZAKBAŞ S., Uzunkopru C., Baba C., Demir S., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.58, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

59. Cerebrospinal fluid level of neurofilament light chain is associated with increased disease activity in neuro-Behcet's disease

Karaaslan Z., Şanlı E., Timirci-Kahraman Ö., Yılmaz V., Akbayır E., Koral G., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.4, ss.1266-1273, 2022 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier identifier

60. Coexistence of restless legs syndrome and multiple sclerosis aggravates anxiety and depression

Sevim S., DEMİRKIRAN D. M., TERZİ M., YÜCEYAR A. N., Tasdelen B., İDİMAN E., et al.
ARQUIVOS DE NEURO-PSIQUIATRIA , cilt.80, ss.168-172, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier

61. Anti-GAD associated post-infectious cerebellitis after COVID-19 infection

Emekli A. S., Parlak A., Gocen N. Y., Kurtuncu M.
NEUROLOGICAL SCIENCES , sa.10, ss.3995-4002, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

62. Detailed Evaluation of Macular Ganglion Cell Complex in Patients with Multiple Sclerosis

Özbilen K. T., Gündüz T., Kartal S. N. Ç., Aksu Ceylan N., Eraksoy M., Kürtüncü M.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.58, sa.3, ss.176-183, 2021 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier identifier

63. Clinical and Molecular Genetic Findings of Cerebral Arteriopathy with Subcortical Infarcts and Leukoencephalopathy

Rustemoglu B. S., Samancı B., Tepgec F., Kürtüncü M., Altunoglu U., Gündüz T., et al.
TURKISH JOURNAL OF NEUROLOGY , cilt.27, sa.3, ss.240-247, 2021 (ESCI, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

64. Evaluating the effects of transcutaneous tibial nerve stimulation or pelvic floor muscle training on sexual dysfunction in female multiple sclerosis patients reporting overactive bladder

POLAT DÜNYA C., TÜLEK Z., Kurtuncu M., Gunduz T., Panicker J. N., Eraksoy M.
NEUROUROLOGY AND URODYNAMICS , cilt.40, sa.6, ss.1661-1669, 2021 (SCI-Expanded) identifier identifier identifier

65. Paraneoplastic cerebellar degeneration in a patient with multiple myeloma

KÜRTÜNCÜ M., TÜZÜN E.
LEUKEMIA & LYMPHOMA , cilt.62, sa.10, ss.2556-2557, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

66. Effects of Teriflunomide on B Cell Subsets in MuSK-Induced Experimental Autoimmune Myasthenia Gravis and Multiple Sclerosis

YILMAZ V., Ulusoy C., Hajtovic S., Turkoglu R., Kurtuncu M., Tzartos J., et al.
Immunological Investigations , cilt.50, ss.671-684, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

67. Bruch's membrane opening-minimum rim width: An alternative OCT biomarker study for multiple sclerosis

Ozbilen K. T., Gunduz T., Kartal S. N. C., Gedik A. C., Eraksoy M., Kurtuncu M.
EUROPEAN JOURNAL OF OPHTHALMOLOGY , cilt.31, ss.2141-2149, 2021 (SCI-Expanded) identifier identifier identifier

68. The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real-world study from Turkey

Uzunkopru C., Tutuncu M., Gunduz T., GÜMÜŞ H., Sen S., Demir S., et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.75, sa.7, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

69. Impact of Autoimmune Demyelinating Brain Disease Sera on Pericyte Survival

Ulusoy C., Şekerdağ E., YILMAZ V., Yilmaz A. B., Atak D., Vural A., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , sa.2, ss.83-86, 2021 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier identifier

70. Effectiveness of the transcutaneous tibial nerve stimulation and pelvic floor muscle training with biofeedback in women with multiple sclerosis for the management of overactive bladder

POLAT DÜNYA C., TÜLEK Z., Kurtuncu M., Panicker J. N., Eraksoy M.
MULTIPLE SCLEROSIS JOURNAL , cilt.27, sa.4, ss.621-629, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

71. Clinical Features of the Patients with Neuromyelitis Optica Spectrum Disorder

Cakar A., Ulusoy C., Gunduz T., Kucukali C. I., Kurtuncu M.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.58, sa.1, ss.21-25, 2021 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier identifier

72. Translation, cross-cultural adaptation, and reliability and validity of the Turkish version of the SF-Qualiveen in people with multiple sclerosis

ZENGİNLER YAZGAN Y., TARAKCI E., Ovacik U., Kurtuncu M.
NEUROUROLOGY AND URODYNAMICS , cilt.40, sa.3, ss.891-896, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

73. CSF levels of HoxB3 and YKL-40 may predict conversion from clinically isolated syndrome to relapsing remitting multiple sclerosis.

Tamam Y., Gunes B., Akbayir E., Kizilay T., Karaaslan Z., Koral G., et al.
Multiple sclerosis and related disorders , cilt.48, sa.1, ss.102697, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

74. Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population

Yalcin G. Y., POLAT DÜNYA C., TÜLEK Z., KÜRTÜNCÜ M., ERAKSOY M.
TURKISH JOURNAL OF NEUROLOGY , cilt.27, ss.31-39, 2021 (ESCI, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

75. Preface

TÜZÜN E., KÜRTÜNCÜ M.
Neuro-Behçet's Disease: Pathogenesis, Clinical Aspects, Treatment , cilt.25, ss.2, 2021 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

76. Serum antiganglioside antibodies in patients with autoimmune limbic encephalitis

Culha Oktar A., Selcuk O., Elmas Tunc C., IŞILDAK Ş., ŞANLI E., YILMAZ V., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.5, ss.2570-2574, 2021 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

77. Understanding the impact of cognitive impairment and disease severity on activities of daily living in MS patients with different disability levels

ZENGİNLER YAZGAN Y., TARAKCI E., GÜNGÖR F., Kurtuncu M.
CLINICAL NEUROLOGY AND NEUROSURGERY , cilt.200, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

78. The risk of endothelial and erectile dysfunctions in Behcet's disease: a comparative analysis of mucocutaneous and systemic patient groups

Erdem Y., Erdem S., Barburoglu M., Karaayvaz E. B., Shugaiv E., Kurtuncu M., et al.
POSTEPY DERMATOLOGII I ALERGOLOGII , cilt.38, sa.4, ss.622-628, 2021 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

79. Adult-onset 4H leukodystrophy: a case presentation and review of the literature

Uygun O., Gunduz T., Eraksoy M., Kurtuncu M.
ACTA NEUROLOGICA BELGICA , cilt.120, sa.6, ss.1461-1462, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

80. A case report with tuberculous meningitis during fingolimod treatment

Koseoglu M., Celik R. G. G., KÜRTÜNCÜ M.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.46, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

81. A Case of HaNDL with Low Cerebrospinal Fluid Level of Neurofilament Light Chain

Sisman A. B., Bayar M. D., İçöz S., YILMAZ V., Kürtüncü M., TÜZÜN E., et al.
Case Reports in Neurology , cilt.12, sa.3, ss.334-338, 2020 (ESCI, Scopus) identifier identifier identifier

82. Laboratory and clinical correlates of brain atrophy in Neuro-Behçet's disease

Gündüz T., Kürtüncü M., Matur Z., Tüzün E., Limon U., Tanyildiz B., et al.
Journal of the Neurological Sciences , cilt.414, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

83. 'Is RLS a harbinger and consequence of MS?: Striking results of the 'RELOMS-T' study'

Sevim S., Demirkiran M., TERZİ M., YÜCEYAR A. N., Tasdelen B., İDİMAN E., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.42, 2020 (SCI-Expanded) identifier identifier identifier

84. Aquaporin-4 Gene Polymorphisms in Neuromyelitis Optica and Recurrent Optic Neuritis

Çakar A., Ulusoy C. A., İplik E. S., Küçükali C. İ., Tüzün E., Kürtüncü M.
Turkish Journal of Neurology , cilt.26, sa.2, ss.127-130, 2020 (Hakemli Dergi)

85. Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing-Remitting Multiple Sclerosis Patients? A Narrative Review

AlSharoqi I. A., Aljumah M., Bohlega S., BOZ C., Daif A., El-Koussa S., et al.
NEUROLOGY AND THERAPY , cilt.9, sa.1, ss.55-66, 2020 (SCI-Expanded, ESCI, Scopus) identifier identifier identifier

86. Comparison of the effects of two different exergaming systems on balance, functionality, fatigue, and quality of life in people with multiple sclerosis: A randomized controlled trial

ZENGİNLER YAZGAN Y., TARAKCI E., TARAKCI E., RAZAK ÖZDİNÇLER A., Kurtuncu M.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.39, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

87. Fingolimod Therapy for Pediatric Relapsing-Remitting Multiple Sclerosis: A Real-Life Study

Ilki C. D., Gunduz T., Kurtuncu M., Yapici Z., Sencer S., Eraksoy M.
TURKISH JOURNAL OF NEUROLOGY , cilt.26, sa.1, ss.34-38, 2020 (ESCI, Scopus, TRDizin) identifier identifier

88. Aquaporin-4 Gene Polymorphisms in Neuromyelitis Optica and Recurrent Optic Neuritis

ÇAKAR A., ULUSOY C. A., BİRELLER E. S., KÜÇÜKALİ C. İ., TÜZÜN E., KÜRTÜNCÜ M.
TURKISH JOURNAL OF NEUROLOGY , cilt.26, sa.2, ss.122-125, 2020 (ESCI, Scopus, TRDizin) identifier identifier identifier

89. Validation of the Turkish version of the eight-item actionable bladder symptom screening tool in multiple sclerosis

POLAT DÜNYA C., TÜLEK Z., Vizviz G. Y., Gunduz T., Panicker J. N., Kurtuncu M., et al.
NEUROUROLOGY AND URODYNAMICS , cilt.39, sa.1, ss.243-252, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

90. Impact of fingolimod on CD4+T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients

Kurtuncu M., Yilmaz V., Akcay H. I., Turkoglu R., Altunrende B., Cinar S., et al.
JOURNAL OF NEUROIMMUNOLOGY , cilt.337, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

91. Differences Between General Neurologists and Multiple Sclerosis Specialists in the Management of Multiple Sclerosis Patients: A National Survey

Kurtuncu M., Tuncer A., Uygunoglu U., Caliskan Z., Kokenli Paksoy A., EFENDİ H., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.56, sa.4, ss.269-272, 2019 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

92. Psoriasiform eruption caused by teriflunomide in a patient with multiple sclerosis

Agirgol S., Kurtuncu M., Gurbuzel M., Tasyurek I., Gunduz T.
CLINICAL TOXICOLOGY , cilt.57, sa.11, ss.1125-1127, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

93. Enhanced NLRP3 and DEFA1B Expression During the Active Stage of Parenchymal Neuro-Behcet's Disease

UGUREL E., ERDAG E., KUCUKALI C. İ., OLCAY A., Sanli E., AKBAYIR E., et al.
IN VIVO , cilt.33, sa.5, ss.1493-1497, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

94. Identification of candidate biomarkers in converting and non-converting clinically isolated syndrome by proteomics analysis of cerebrospinal fluid

Timirci-Kahraman O., Karaaslan Z., Tuzun E., Kurtuncu M., Baykal A. T., Gunduz T., et al.
ACTA NEUROLOGICA BELGICA , sa.1, ss.101-111, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

95. Microbiota stratification identifies disease-specific alterations in neuro-Behcet's disease and multiple sclerosis

Oezguen N., Yalcinkaya N., Kucukali C. I., Dahdouli M., Hollister E. B., Luna R. A., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.37, sa.6, ss.58-66, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

96. Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

Dogan F. U., Kurtuncu M.
TURKISH JOURNAL OF NEUROLOGY , cilt.25, sa.1, ss.52-53, 2019 (ESCI, Scopus, TRDizin) identifier

97. Paraplegia following lumbar puncture: a rare complication in spinal dural arteriovenous fistula

Cakar A., Akcay H. I., Gunduz T., Kurtuncu M.
ACTA NEUROLOGICA BELGICA , cilt.118, sa.4, ss.543-545, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

98. MULTIPLE SCLEROSIS BURDEN OF ILLNESS STUDY FOR TURKEY

Senturk A., Altintas A., Kocaman S. A., Irkec C., Kuscu Y. D., Yildirim A. K., et al.
VALUE IN HEALTH , 2018 (SCI-Expanded, SSCI, Scopus) identifier

99. Prognostic Factors in Anti-Neurona Antibody Positive Patients

Aydin C., Celik S. Y., Icoz S., Ulusoy C. A., Gunduz T., Akman Demir G., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.55, sa.2, ss.189-194, 2018 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

100. Clinical and Prognostic Evaluation of Myelin Oligodendrocyte Glycoprotein Autoimmunity in the Central Nervous System

Tasdemir V., Kurtuncu M.
TURKISH JOURNAL OF NEUROLOGY , cilt.24, sa.4, ss.350-351, 2018 (ESCI, Scopus, TRDizin) identifier

101. Effect of smoking on disability progression in patients with multiple sclerosis

Gunduz T., Kurtuncu M.
TOBACCO INDUCED DISEASES , cilt.16, ss.28, 2018 (SCI-Expanded, SSCI, Scopus) identifier

102. Mortality in Patients with Multiple Sclerosis

Samli S., Kurtuncu M.
TURKISH JOURNAL OF NEUROLOGY , cilt.24, sa.1, ss.107-108, 2018 (ESCI) identifier

103. Cerebrospinal Fluid Analysis of Pericytic Mediators in Clinically Isolated Syndrome and Multiple Sclerosis: A Preliminary Study

GÜNDÜZ T., TANYEL KİREMİTÇİ T., ULUSOY C. A., KÜRTÜNCÜ M., TÜRKOĞLU R.
Experimed , cilt.81, sa.1, ss.18-22, 2018 (TRDizin)

104. How long should we treat Neuro-Behcet's disease?

Kurtuncu M., Gunduz T., Aydin B. N., Akman G.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.6, 2018 (SCI-Expanded, Scopus) identifier

105. Nasu-Hakola Disease.

Samanci B., Ulukan Ç., Gündüz T., Kürtüncü M., Eraksoy M.
Neurology India , cilt.66, ss.263, 2018 (SCI-Expanded, Scopus) identifier identifier

106. Validity and Reliability of the Turkish Version of the Multiple Sclerosis-Related Symptom Checklist

Tulek Z., Polat C., Kurtuncu M., Eraksoy M.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , sa.4, ss.328-333, 2017 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier identifier

107. Glial and neuronal antibodies in patients with idiopathic intracranial hypertension

Altiokka-Uzun G., Erdag E., Baykan B., TZARTOS J., Gezen-Ak D., Samanci B., et al.
NEUROLOGICAL SCIENCES , sa.10, ss.1817-1822, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

108. Validity and Reliability of the Turkish Version of the Monitoring My Multiple Sclerosis Scale

Polat C., Tulek Z., Kurtuncu M., Eraksoy M.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , sa.2, ss.131-138, 2017 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier identifier

109. Effects of in vivo and in vitro administration of neuro-Behcet's disease IgG

Erdag E., Sahin C., Kucukali C. İ., Bireller S., Kucukerden M., Kurtuncu M., et al.
NEUROLOGICAL SCIENCES , sa.5, ss.833-843, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

110. Neurobrucellosis presenting with mania

Akcay H. I., Kurtuncu M., Celik S. Y., Gunduz T., Eraksoy M.
ACTA NEUROLOGICA BELGICA , cilt.117, sa.1, ss.373-375, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

111. Severe rebound after withdrawal of fingolimod treatment in patients with multiple sclerosis

Gunduz T., Kurtuncu M., Eraksoy M.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.11, ss.1-3, 2017 (SCI-Expanded) identifier identifier identifier

112. Characteristics of isolated spinal cord involvement in neurobrucellosis with no corresponding MRI activity: A case report and review of the literature

Gunduz T., Tekturk P., Yapici Z., Kurtuncu M., Somer A., Torun S., et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES , ss.305-306, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

113. Reduced fecal GABA levels in multiple sclerosis patients

Yalcinkaya N., Akcan U., Orcen A., Kucukali C. İ., Tuzun E., TURKOGLU R., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , ss.60-61, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

114. Behcet's Disease and Nervous System Involvement

Kurtuncu M., Tuzun E., AKMAN-DEMIR G.
CURRENT TREATMENT OPTIONS IN NEUROLOGY , cilt.18, sa.5, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

115. Increased complexin-1 and decreased miR-185 expression levels in Beh‡et's disease with and without neurological involvement

Ugurel E., Sehitoglu E., Tuzun E., Kurtuncu M., Coban A., Vural B.
NEUROLOGICAL SCIENCES , sa.3, ss.411-416, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

116. Autoimmune Diseases Associated with Epilepsy

Kurtuncu M., Altunrende B., Demir G. A.
EPILEPSI , cilt.22, ss.53-66, 2016 (ESCI, Scopus, TRDizin) identifier identifier identifier

117. Does Clopidogrel have an Effect on Migraine Attacks that Emerge after Closure of Atrial Septal Defects?

Akcay H. I., Kurtuncu M.
TURKISH JOURNAL OF NEUROLOGY , cilt.22, sa.2, ss.95-96, 2016 (ESCI, Scopus, TRDizin) identifier

118. Oligoclonal bands and increased cytokine levels in idiopathic intracranial hypertension

Altiokka-Uzun G., Tuzun E., Ekizoglu E., Ulusoy C. A., Yentur S., Kurtuncu M., et al.
CEPHALALGIA , sa.13, ss.1153-1161, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

119. Behcet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria

AKMAN-DEMIR G., Mutlu M. O., KIYAT-ARAMER A., Shugaiv E., Kurtuncu M., Tugal-Tutkun I., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.33, sa.6, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

120. Reduced serum vitamin D levels in neuromyelitis optica

Tuzun E., Kucukhuseyin Ö., Kurtuncu M., TURKOGLU R., Yaylim I.
NEUROLOGICAL SCIENCES , sa.9, ss.1701-1702, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

121. Untitled

KÜRTÜNCÜ M.
TURKISH JOURNAL OF NEUROLOGY , cilt.32, sa.4, 2015 (ESCI, Scopus) identifier identifier identifier

122. Association of Demyelinating and Inflammatory Bowel Diseases: A Case Series and Overview of the Literature

Atmaca M. M., Uzun G. A., SHUGAIV E., Kurtuncu M., Eraksoy M.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.52, sa.3, ss.315-318, 2015 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

123. Antibodies to DNA repair proteins in headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL) patients

Erdag E., ÇELEBİSOY N., YÜCEYAR A. N., Kurtuncu M., Vural B., Tuzun E.
ACTA NEUROLOGICA BELGICA , cilt.115, sa.2, ss.137-140, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

124. Epigenetics of Multiple Sclerosis: An Updated Review

Kucukali C. İ., Kurtuncu M., Coban A., Cebi M., Tuzun E.
NEUROMOLECULAR MEDICINE , sa.2, ss.83-96, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

125. Predictive value of early serum cytokine changes on long-term interferon beta-1a efficacy in multiple sclerosis

PETEK-BALCI B., Coban A., Shugaiv E., TURKOGLU R., Ulusoy C., Icoz S., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE , sa.5, ss.352-356, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

126. Drop-out Rate of Glatiramer Acetate is Influenced by Body Mass Index in Multiple Sclerosis Patients

KÜRTÜNCÜ M., Cinar B. C., Yildiz C. S., ÇOBAN A., Pehlivan M., ERAKSOY M.
MULTIPLE SCLEROSIS JOURNAL , cilt.21, sa.6, ss.818, 2015 (SCI-Expanded, Scopus) identifier

127. Peripheral nerve hyperexcitability syndromes

Kucukali C. İ., Kurtuncu M., Akcay H. I., Tuzun E., Oge A. E.
REVIEWS IN THE NEUROSCIENCES , sa.2, ss.239-251, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

128. Highlights in headache in 2014

YALİNAY DİKMEN P., KÜRTÜNCÜ M.
Turk Noroloji Dergisi , cilt.21, sa.1, 2015 (Scopus) identifier

129. Does Central Nervous System have a Lymphatic Circulation?

Gunduz T., Akcay H. I., Kurtuncu M.
TURKISH JOURNAL OF NEUROLOGY , cilt.21, sa.4, ss.179-180, 2015 (ESCI, Scopus) identifier

130. Is Very Early Mobilization after Stroke Effective?

Gunduz T., Akcay H. I., Kurtuncu M.
TURKISH JOURNAL OF NEUROLOGY , cilt.21, sa.4, ss.179, 2015 (ESCI, Scopus) identifier

131. Uveitis as a prognostic factor in multiple sclerosis

Shugaiv E., Tuzun E., Kurtuncu M., Kiyat-Atamer A., Coban A., Akman-Demir G., et al.
MULTIPLE SCLEROSIS JOURNAL , sa.1, ss.105-107, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

132. Frontiers in neurology Nörolojide Öne Çıkanlar

GÜNDÜZ T., Akçay H. İ., KÜRTÜNCÜ M.
Turk Noroloji Dergisi , cilt.21, sa.4, ss.179-181, 2015 (Scopus) identifier

133. Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients

Kucukali C. İ., Haytural H., Benbir G., Coban A., Ulusoy C., Giris M., et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES , sa.1-2, ss.353-355, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

134. Multiple Skleroz ve Kronik Polinöropati Birlikteliği Olgu Sunumu

SHUGAIV E., YUMERHODZHA S., GÜNGÖR İ., YAVUZ E. N., KÜRTÜNCÜ M., BASLO M. B., et al.
Klinik Tıp Aile Hekimliği , 2014 (Hakemsiz Dergi)

135. Use of acetazolamide in idiopathic intracranial hypertension

KÜRTÜNCÜ M.
Turk Noroloji Dergisi , cilt.20, sa.4, ss.145-146, 2014 (Scopus) identifier

136. Aquaporin-1 Antibody in Neuromyelitis Optica Patients

Tuzun E., TZARTOS J., Ekizoglu E., STERGIOU C., ZISIMOPOULOU P., Coban A., et al.
EUROPEAN NEUROLOGY , sa.5-6, ss.271-272, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

137. The effect of intravenous metoclopramide and valproate in acute migraine

KÜRTÜNCÜ M.
Turk Noroloji Dergisi , cilt.20, sa.4, ss.145, 2014 (Scopus) identifier

138. Neurology News Nörolojide öne çi{dotless}kanlar

Ibrahim Akçay H., KÜRTÜNCÜ M.
Turk Noroloji Dergisi , cilt.19, sa.4, ss.157-159, 2013 (Scopus) identifier

139. Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica

Woodhall M., Coban A., Waters P., Eldzoglu E., Kurtuncu M., Shugaiv E., et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES , sa.1-2, ss.221-223, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

140. Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behcet's disease

Vural B., Sehitoglu E., Cavus F., Yalcinkaya N., Haytural H., Kucukerden M., et al.
JOURNAL OF NEUROIMMUNOLOGY , sa.1-2, ss.139-144, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

141. MTCH1 antibodies in neuromyelitis optica patients with or without aquaporin-4 antibodies

Coban A., Cavus F., Ulusoy C., Turan S., Vural B., Turkoglu R., et al.
JOURNAL OF NEUROLOGY , 2013 (SCI-Expanded) identifier

142. Long-term MRI findings in neuromyelitis optica: seropositive versus seronegative patients

KIYAT-ATAMER A., Ekizoglu E., Tuzun E., Kurtuncu M., Shugaiv E., AKMAN-DEMIR G., et al.
EUROPEAN JOURNAL OF NEUROLOGY , sa.5, ss.781-787, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

143. Intrathecal oligoclonal IgG bands are infrequently found in neuro-Behcet's disease

Saruhan-Direskeneli G., Yentur S. P., Mutlu M. O., Shugaiv E., Yesilot N., Kurtuncu M., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.3, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

144. Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures

Durmus H., Kurtuncu M., Tuzun E., Pehlivan M., Akman-Demir G., Yapici Z., et al.
Acta Neurologica Belgica , cilt.113, sa.4, ss.421-426, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

145. Progressive Encephalomyelitis with Rigidity and Myoclonus: A Syndrome with Diverse Clinical Features and Antibody Responses

Shugaiv E., Leite M. I., Sehitoglu E., Woodhall M., Cavus F., Waters P., et al.
EUROPEAN NEUROLOGY , sa.5, ss.257-262, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

146. Cerebrotendinous Xanthomatosis with Cerebellar Vacuolation

Shugaiv E., Ibrahimova G., Karaaslan Z., Bozkaya A. C., Kurtuncu M., ERAKSOY M.
TURKISH JOURNAL OF NEUROLOGY , sa.1, ss.39, 2013 (ESCI, Scopus) identifier

147. CACNA1H antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL)

Kurtuncu M., KAYA D., Zuliani L., Erdag E., Icoz S., Ugurel E., et al.
CEPHALALGIA , cilt.33, sa.2, ss.123-129, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

148. Kleptomania in Patients with Neuro-Behcet's Disease

Shugaiv E., Kiyat-Atamer A., Tuzun E., Kurtuncu M., Baral-Kulaksizoglu I., Demir G. A.
MEDICAL PRINCIPLES AND PRACTICE , sa.6, ss.550-554, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

149. Cognitive Impairment in Neuro-Behcet's Disease and Multiple Sclerosis: A Comparative Study

Gunduz T., Emir O., Kurtuncu M., Mutlu M., Tumac A., Akca S., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE , sa.11, ss.650-656, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

150. Effect of short-term interferon-beta treatment on cytokines in multiple sclerosis: Significant modulation of IL-17 and IL-23

Kurtuncu M., Tuzun E., TURKOGLU R., PETEK-BALCI B., Icoz S., Pehlivan M., et al.
CYTOKINE , cilt.59, sa.2, ss.400-402, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

151. Comparison of the Cytokine Profiles of Patients With Neuronal-Antibody-Associated Central Nervous System Disorders

Ulusoy C., Tuzun E., Kurtuncu M., TURKOGLU R., Akman-Demir G., Eraksoy M.
INTERNATIONAL JOURNAL OF NEUROSCIENCE , sa.6, ss.284-289, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

152. Standing Out in Neurology

KÜRTÜNCÜ M.
TURKISH JOURNAL OF NEUROLOGY , sa.4, ss.180-182, 2012 (ESCI, Scopus) identifier

153. Perineural cyst presenting like cubital tunnel syndrome.

Bayrakli F., KÜRTÜNCÜ M., Karaarslan E., Ozgen S.
European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society , cilt.21 Suppl 4, 2012 (SCI-Expanded, Scopus) identifier identifier

154. Natalizumab Treatment in Multiple Sclerosis

KÜRTÜNCÜ M.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.48, ss.56-60, 2011 (SCI-Expanded, Scopus, TRDizin) identifier

155. Clinical characteristics of pediatric-onset neuro-Behcet disease

Uluduz D., Kurtuncu M., Yapici Z., Seyahi E., Kasapcopur O., Ozdogan H., et al.
NEUROLOGY , sa.21, ss.1900-1905, 2011 (SCI-Expanded, Scopus) identifier identifier identifier

156. Anti-neuronal and stress-induced-phosphoprotein 1 antibodies in neuro-Behcet's disease

Vural B., Ugurel E., Tuzun E., Kurtuncu M., Zuliani L., Cavus F., et al.
JOURNAL OF NEUROIMMUNOLOGY , sa.1-2, ss.91-97, 2011 (SCI-Expanded, Scopus) identifier identifier identifier

157. Increased Alcohol Consumption Rates of Multiple Sclerosis Patients and Their Parents

Pehlivan M., Kurtuncu M., Yargic I., Tuzun E.
AMERICAN JOURNAL ON ADDICTIONS , cilt.20, sa.5, ss.488-489, 2011 (SSCI, Scopus) identifier identifier identifier

158. The comparison of socio-economic conditions and personal hygiene habits of neuro-Behcet's disease and multiple sclerosis patients

Pehlivan M., Kurtuncu M., Tuzun E., Shugaiv E., Mutlu M., Eraksoy M., et al.
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH , cilt.214, sa.4, ss.335-337, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

159. Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Behcet's disease with parenchymal involvement: presentation of four cases

Shugaiv E., Tuzun E., Mutlu M. O., Kiyat-Atamer A., Kurtuncu M., Akman-Demir G.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.4, 2011 (SCI-Expanded, Scopus) identifier identifier identifier

160. Enhanced complement consumption in neuromyelitis optica and Behcet's disease patients

Tuzun E., Kurtuncu M., TURKOGLU R., Icoz S., Pehlivan M., Birisik O., et al.
JOURNAL OF NEUROIMMUNOLOGY , sa.1-2, ss.211-215, 2011 (SCI-Expanded) identifier identifier identifier

161. Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients

Akman-Demir G., Tuzun E., Waters P., Icoz S., Kurtuncu M., Jarius S., et al.
JOURNAL OF NEUROLOGY , sa.3, ss.464-470, 2011 (SCI-Expanded) identifier identifier identifier

162. Susceptibility-Weighted imaging in migraine with aura

KARAARSLAN E., Ulus S., KÜRTÜNCÜ M.
American Journal of Neuroradiology , cilt.32, sa.1, 2011 (SCI-Expanded, Scopus) identifier identifier

163. Antineuronal Antibodies in Migraine Patients With White Matter Lesions

TURKOGLU R., Tuzun E., Icoz S., Birisik O., Erdag E., Kurtuncu M., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE , sa.1, ss.33-36, 2011 (SCI-Expanded, Scopus) identifier identifier identifier

164. Autoantibodies to neuronal surface antigens in thyroid antibody-positive and -negative limbic encephalitis

Tuzun E., Erdag E., Durmus H., Brenner T., Turkoglu R., Kurtuncu M., et al.
NEUROLOGY INDIA , cilt.59, sa.1, ss.47-50, 2011 (SCI-Expanded, Scopus) identifier identifier identifier

165. Bickerstaff's encephalitis and Miller Fisher syndrome associated with voltage-gated potassium channel and novel anti-neuronal antibodies

Tuzun E., Kurtuncu M., Lang B., Icoz S., Akman-Demir G., Eraksoy M., et al.
EUROPEAN JOURNAL OF NEUROLOGY , sa.10, ss.1304-1307, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

166. PERSONAL HYGIENE HABITS OF BEHCET'S DISEASE PATIENTS: CAN BAD HYGIENE CAUSE BEHCET'S DISEASE?

Akman-demir G., Pehlivan M., Shugaiv E., Tuzun E., Kurtuncu M.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded) identifier

167. COMPLEMENT PATHWAYS INVOLVED IN THE INFLAMMATORY CENTRAL NERVOUS SYSTEM DISORDERS

Tuzun E., Akman-demir G., Kurtuncu M., Icoz S., Birisik O., Eraksoy M.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded) identifier

168. Amphiphysin Autoimmunity: Associated Neurological Syndromes and Tumors in The Turkish Population

Tuzun E., Bebek N., Icoz S., Durmus H., Kurtuncu M., Gurses C., et al.
JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH , cilt.27, sa.2, ss.121-126, 2010 (SCI-Expanded, TRDizin) identifier identifier identifier

169. Intraventricular Hemorrhage as an Unusual Presenting Form of Sneddon Syndrome

Bayrakli F., ÖZTÜRK DURMAZ E., KÜRTÜNCÜ M., Ozgen S.
WORLD NEUROSURGERY , cilt.73, sa.4, ss.411-413, 2010 (SCI-Expanded, Scopus) identifier

170. A rare case of multiple sclerosis and cerebral hemorrhage associated with osteopetrosis

KAYA D., Tüzün E., DİNÇER A., PAMİR M. N., Kürtüncü M.
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY , sa.1, ss.16-19, 2010 (SCI-Expanded) identifier identifier identifier

171. Enhanced IL-6 Production in Aquaporin-4 Antibody Positive Neuromyelitis Optica Patients

Icoz S., Tuzun E., Kurtuncu M., Durmus H., Mutlu M., Eraksoy M., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE , sa.1, ss.71-75, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

172. Impact of Earthquake on Multiple Sclerosis Attacks

Tuzun E., Polat A., Akman-Demir G., Kurtuncu M., Mutlu M., Aksay B., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , sa.4, ss.324-327, 2010 (SCI-Expanded) identifier identifier

173. Rare Neurological Syndromes Associated with Systemic Lupus Erythematosus

Durmus H., Tuzun E., Alpay N., Icoz S., Kurtuncu M., Demir G. A.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.47, sa.1, ss.81-82, 2010 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

174. Primary cerebral lymphoma with a 5-year remission to single-agent corticosteroids

Kurtuncu M., Tuzun E., Durmus H., Mutlu M., Akman-Demir G., Eraksoy M.
Leukemia and Lymphoma , cilt.50, sa.9, ss.1552-1553, 2009 (SCI-Expanded, Scopus) identifier identifier identifier

175. Pregnancy-induced atypic demyelinating inflammatory disease Gebelikle Tetiklenen Atipik İnflamatuvar Demiyelinizan Hastalιk

Durmus H., Tüzün E., Kürtüncü M., MUTLU M., DEMIR G. A., Eraksoy M.
Noropsikiyatri Arsivi , cilt.46, sa.2, ss.80-83, 2009 (SCI-Expanded) identifier

176. Cerebral venous thrombosis in Beh‡et's disease compared to those associated with other etiologies

Yesilot N., Bahar S., Yılmazer S., Mutlu M. O., Kurtuncu M., Tuncay R., et al.
JOURNAL OF NEUROLOGY , sa.7, ss.1134-1142, 2009 (SCI-Expanded) identifier identifier identifier

177. Pregnancy-Induced Atypic Demyelinating Inflammatory Disease

Durmus H., Tuzun E., Kurtuncu M., Mutlu M., Demir G. A., Eraksoy M.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , sa.2, ss.80-83, 2009 (SCI-Expanded, Scopus, TRDizin) identifier identifier

178. Anti-Yo-associated cerebellar syndrome presenting with a brain mass

Tuzun E., BEKTAS H. M., Icoz S., Kurtuncu M., SAIP P., Akman-Demir G.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY , sa.2, ss.183-184, 2009 (SCI-Expanded, Scopus) identifier identifier identifier

179. Development of Multiple Sclerosis in Patients with Optic Neuritis: Analysis of Predictive Factors

Durmuş Tekçe H., Kürtüncü M., Tüzün E., Akalın B., Mutlu M., Akman-Demir G., et al.
Turkish Journal of Neurology , cilt.15, sa.3, ss.119-123, 2009 (Hakemli Dergi) Creative Commons License

180. Development of Multiple Sclerosis in Patients with Optic Neuritis: Analysis of Predictive Factors

Durmus H., Kurtuncu M., TÜZÜN E., Akalin B. E., Mutlu M., Demir G. A., et al.
TURKISH JOURNAL OF NEUROLOGY , cilt.15, sa.3, ss.119-123, 2009 (ESCI, TRDizin) Sürdürülebilir Kalkınma identifier

181. Interleukin-6 in neuro-Behcet's disease: Association with disease subsets and long-term outcome

Akman-Demir G., Tuezuen E., Icoez S., Yesilot N., Yentuer S. P., Kuertuencue M., et al.
CYTOKINE , sa.3, ss.373-376, 2008 (SCI-Expanded) identifier identifier identifier

182. Multiple sclerosis: Could it be an epigenetic disease?

Kurtuncu M., Tuzun E.
MEDICAL HYPOTHESES , cilt.71, sa.6, ss.945-947, 2008 (SCI-Expanded) identifier identifier identifier

183. Elevated IL-6 levels in the cerebrospinal fluid of neuromyelitis optica patients

Tuzun E., Akman-Demir G., Icoz S., Kurtuncu M., Eraksoy M.
JOURNAL OF NEUROIMMUNOLOGY , cilt.203, sa.2, ss.179-180, 2008 (SCI-Expanded, Scopus) identifier

184. Devic's neuromyelitis optica: Prognostic implications of NMO IgG status in Turkish patients

Akman-Demir G., Tuzun E., Jarius S., Icoz S., Kurtuncu M., Waters P., et al.
JOURNAL OF NEUROIMMUNOLOGY , cilt.203, sa.2, ss.184, 2008 (SCI-Expanded, Scopus) identifier

185. Anti-neuronal antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis

Kurtuncu M., Tuzun E., KAYA D., Icoz S., Baslo M. B., Ertas M., et al.
JOURNAL OF HEADACHE AND PAIN , cilt.9, sa.5, ss.333-335, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

186. PEDIATRIC NEURO-BEHCET'S SYNDROME

Akman-Demir G., Saip S., Uluduz D., Kurtuncu M., Seyahi E., Tugal-Tutkun I., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.4, 2008 (SCI-Expanded, Scopus) identifier

187. Cyclosporine for Behcet's uveitis: is it associated with an increased risk of neurological involvement?

Akman-Demir G., Ayranci O., Kurtuncu M., Vanli E. N., Mutlu M., Tugal-Tutkun I.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.4, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

188. CLINICAL PATTERNS AND COURSE OF NEURO-BEHCET'S DISEASE: ANALYSIS OF 354 PATIENTS COMPARING CASES PRESENTED BEFORE AND AFTER 1990

Kurtuncu M., Tuzun E., Mutlu M., Pehlivan M., Serdaroglu R., Akman-Demir G.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.4, 2008 (SCI-Expanded) identifier

189. Effects of cocaine in 5-lipoxygenase-deficient mice

KÜRTÜNCÜ M., Battista N., Uz T., D'Agostino A., Dimitrijevic N., Pasquariello N., et al.
JOURNAL OF NEURAL TRANSMISSION , cilt.115, sa.3, ss.389-395, 2008 (SCI-Expanded, Scopus) identifier

190. The incidence and significance of anti-natalizumab antibodies -: Results from AFFIRM and SENTINEL

Calabresi P. A., Giovannoni G., Confavreux C., Galetta S. L., Havrdova E., Hutchinson M., et al.
NEUROLOGY , sa.14, ss.1391-1403, 2007 (SCI-Expanded) identifier identifier identifier

191. Neurosyphilis presenting with status epilepticus

Gurses C., Kurtuncu M., Jirsch J., Yesilot N., Hanagasi H. A., Bebek N., et al.
EPILEPTIC DISORDERS , cilt.9, sa.1, ss.51-56, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

192. Impaired hippocampal long-term potentiation in melatonin MT2 receptor-deficient mice

Larson J., Jessen R., Uz T., Arslan A., KÜRTÜNCÜ M., Imbesi M., et al.
NEUROSCIENCE LETTERS , cilt.393, sa.1, ss.23-26, 2006 (SCI-Expanded) identifier

193. MALIGNANT LYMPHOMAAND CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: A CASE REPORT

ÇOBAN A., Kurtuncu M., Isik N., Serdaroglu P., Deymeer F., Parman Y.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , sa.1, ss.19-22, 2006 (ESCI, TRDizin) identifier

194. Reliability assessment of an automated forced swim test device using two mouse strains

KÜRTÜNCÜ M., Luka L., Dimitrijevic N., Uz T., Manev H.
JOURNAL OF NEUROSCIENCE METHODS , cilt.149, sa.1, ss.26-30, 2005 (SCI-Expanded, Scopus) identifier

195. The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system

Uz T., Arslan A., KÜRTÜNCÜ M., Imbesi M., Akhlsaroglu M., Dwivedi Y., et al.
MOLECULAR BRAIN RESEARCH , cilt.136, sa.1-2, ss.45-53, 2005 (SCI-Expanded) identifier

196. Diurnal rhythms in quinpirole-induced locomotor behaviors and striatal D2/D3 receptor levels in mice

Akhisaroglu M., KÜRTÜNCÜ M., Manev H., Uz T.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR , cilt.80, sa.3, ss.371-377, 2005 (SCI-Expanded) identifier

197. Effect of fluoxetine and cocaine on the expression of clock genes in the mouse hippocampus and striatum

Uz T., Ahmed R., Akhisaroglu M., KÜRTÜNCÜ M., Imbesi M., Arslan A., et al.
NEUROSCIENCE , cilt.134, sa.4, ss.1309-1316, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

198. Diurnal rhythms in cocaine sensitization and in Period1 levels are common across rodent species

Akhisaroglu M., Ahmed R., KÜRTÜNCÜ M., Manev H., Uz T.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR , cilt.79, sa.1, ss.37-42, 2004 (SCI-Expanded, Scopus) identifier

199. Involvement of the pineal gland in diurnal cocaine reward in mice

KÜRTÜNCÜ M., Arslan A., Akhisaroglu M., Manev H., Uz T.
EUROPEAN JOURNAL OF PHARMACOLOGY , cilt.489, sa.3, ss.203-205, 2004 (SCI-Expanded, Scopus) identifier

200. The pineal gland and anxiogenic-like action of fluoxetine in mice

Uz T., Dimitrijevic N., Akhisaroglu M., Imbesi M., KÜRTÜNCÜ M., Manev H.
NEUROREPORT , cilt.15, sa.4, ss.691-694, 2004 (SCI-Expanded, Scopus) identifier

201. A whole genome screen for linkage in Turkish multiple sclerosis

Eraksoy M., Kurtuncu M., Akman-Demir G., Kilinc M., Gedizlioglu M., Mirza M., et al.
JOURNAL OF NEUROIMMUNOLOGY , sa.1-2, ss.17-24, 2003 (SCI-Expanded, Scopus) identifier identifier identifier

202. A genome screen for linkage disequilibrium in Turkish multiple sclerosis

Eraksoy M., Hensiek A., Kurtuncu M., Akman-Demir G., Kilinc M., Gedizlioglu M., et al.
JOURNAL OF NEUROIMMUNOLOGY , sa.1-2, ss.129-132, 2003 (SCI-Expanded, Scopus) identifier identifier identifier

203. An open letter to the Committee on the Nobel Prize in Medicine

Abbruzzese G., Agid Y., Albanese A., Alf C., Allen R., Amar K., et al.
PARKINSONISM & RELATED DISORDERS , sa.2, ss.149-155, 2001 (SCI-Expanded, Scopus) identifier identifier identifier

204. Venous infarction of brain stem and cerebellum: Report of two cases and review of the literature

Krespi Y., Gurol M., BİLGİÇ B., KÜRTÜNCÜ M., ÇOBAN O., Tuncay R., et al.
STROKE , cilt.31, sa.11, ss.2822-2823, 2000 (SCI-Expanded, Scopus) identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 178

1. MEDICATION ADHERENCE IN MULTIPLE SCLEROSIS: IMPACT OF DISEASE SUBTYPE AND TREATMENT LINE IN A TERTIARY CARE SETTING

Erdal M., Açıkgöz B., Arı A., Emekli A. S., Koçak E. G., Kurt İ., et al.
ESCP symposium on clinical pharmacy. From interprofessional education to interprofessional practice, Grenoble, Fransa, 26 - 28 Kasım 2025, ss.98, (Özet Bildiri)

2. Nöro-Behçet Hastalığında Çoklu Nörolojik Tutulum Paternleri: Klinik Özellikler ve Hastalık Seyri

Ateş D., Emekli A. S., Gündüz T., Akman G., Kürtüncü M.
61. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 13 - 17 Aralık 2025, ss.138, (Özet Bildiri)

3. The effect of sexual counselling with the PLISSIT model on sexual function and sexual quality of life in women with multiple sclerosis: a randomized controlled trial

POLAT DÜNYA C., TUNCER M., ÖZKAN İ., YALÇIN G. Y., GÜNDÜZ T., KÜRTÜNCÜ M.
ECTRIMS 2025, Barselona, İspanya, 24 - 26 Eylül 2025, (Özet Bildiri) identifier

4. Comparing the Effectiveness of Supervised vs Web-Based Exercise Programs in People with Severe Multiple Sclerosis

Demir T. B., ZENGİNLER YAZGAN Y., KÜRTÜNCÜ M.
41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, İspanya, 24 - 26 Eylül 2025, cilt.31, ss.1302-1303, (Özet Bildiri) identifier

5. Distribution of Cerebral Lesions in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

Manazoglu H., Ayaz T. B., EMEKLİ A. S., GÜNDÜZ T., KÜRTÜNCÜ M.
41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, İspanya, 24 - 26 Eylül 2025, cilt.31, ss.784, (Özet Bildiri) identifier

6. Distribution of Cerebral Lesions in Primary Central Nervous System Vasculitis

Ayaz T. B., EMEKLİ A. S., GÜNDÜZ T., Manazoglu H., Koc E. R., Kotan D., et al.
41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, İspanya, 24 - 26 Eylül 2025, cilt.31, ss.1045, (Özet Bildiri) identifier

7. Real-World Effectiveness and Safety of Eculizumab in AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder: A Multicenter Observational Study

KOÇ E. R., YETKİN M. F., SARIDAŞ F., Turan O. F., Sevim S., Terzi M., et al.
41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, İspanya, 24 - 26 Eylül 2025, cilt.31, ss.729-730, (Özet Bildiri) identifier

8. EDSS Progression and Upper Extremity Disability Worsening in Multiple Sclerosis: Nine-Hole Peg Test Dynamics Across EDSS Strata

GÜNDÜZ T., EMEKLİ A. S., Tezel M., KÜRTÜNCÜ M.
41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, İspanya, 24 - 26 Eylül 2025, cilt.31, ss.210-211, (Özet Bildiri) identifier

9. Forme Fruste Nöro-Behçet Hastalarının Uzun Dönem Takip Sonuçları

Ateş D., Emekli A. S., Gündüz T., Kürtüncü M., Akman G.
12. Nöroimmünoloji Okulu, Girne, Kıbrıs (Kktc), 8 - 11 Mayıs 2025, ss.27, (Özet Bildiri)

10. Clinical and Radiological Features of Anti-MOG Associated Cerebral Cortical Encephalitis

Manazoglu H. C., Dogan I. G., Demir S., KILIÇ A., Ozakbas S., SARIDAŞ F., et al.
Annual Meeting of the American-Academy-of-Neurology (AAN), California, Amerika Birleşik Devletleri, 5 - 09 Nisan 2025, cilt.104, (Özet Bildiri) identifier

11. Exome-sequencing of Turkish Families with Multiple Sclerosis: Low Frequency and Rare Variant Contributions into Susceptibility

Buyukgol F., GÜRDAMAR B., Bulbul A., Sezerman O. U., Everest E., Voyvoda U., et al.
Annual Meeting of the American-Academy-of-Neurology (AAN), California, Amerika Birleşik Devletleri, 5 - 09 Nisan 2025, cilt.104, (Özet Bildiri) identifier

12. Epstein-Barr Virüsü İlişkili Bir Transvers Miyelit Olgusu: Olgu Sunumu

Ateş D., Emekli A. S., Gündüz T., Kürtüncü M.
60. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 27 Kasım - 02 Aralık 2024, ss.280, (Özet Bildiri)

13. Alternate-Day Fingolimod Tapering: Impact on Rebound Disease Activity in Patients with Multiple Sclerosis

Gündüz T., İşkan N. G., Sevimli A., Büke B., Emekli A. S., Kürtüncü M.
The 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Kobenhavn, Danimarka, 18 Eylül 2024, cilt.30, ss.4-124, (Özet Bildiri)

14. Aquaporin-1 antibodies in autoimmune inflammatory demyelinating disorders with predominant optic nerve & spinal cord involvement

TÜZÜN E., Kaptov E., YILMAZ V., Pechlivanidou M., KÜRTÜNCÜ M., GÜNDÜZ T., et al.
40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Danimarka, 18 - 20 Eylül 2024, cilt.30, ss.885, (Özet Bildiri) identifier

15. Alternate-Day Fingolimod Tapering: Impact on Rebound Disease Activity in Patients with Multiple Sclerosis

GÜNDÜZ T., İŞKAN N. G., Sevimli A., BÜKE B., Emekli A. S., KÜRTÜNCÜ M.
40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Danimarka, 18 - 20 Eylül 2024, ss.107, (Özet Bildiri) identifier

16. Otoimmün Demiyelizan Hastalıkların Ayırıcı Tanısında CCL4L2’nin B Hücre Temelli Biyobelirteç Olarak Değeri

Koral G., Akpunar F., Şanlı E., Karaaslan Z., Yüceer H., Özkan E., et al.
59. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 13 - 18 Aralık 2023, ss.89, (Özet Bildiri) Sürdürülebilir Kalkınma

17. Akut İskemik İnmeli Hastaların İnme Sonrası Serumlarında Serebellar Antikorlar

Atmaca M. M., Erdağ E., Demir S., Yüceer Korkmaz H., Çolak Atmaca M., Küçükali C. I., et al.
59. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 13 - 18 Aralık 2023, (Yayınlanmadı)

18. The Effect of Multiple Sclerosis Sera on Pericyte Survival

Akbayir E., Turkoglu R., Ulusoy C. A., Yılmaz V., Kürtüncü M., Küçükali C. İ., et al.
9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.825-826, (Özet Bildiri) identifier

19. Possible Diagnostic Biomarkers in The Differential Diagnosis of Autoimmune Demyelinating Central Nervous System Diseases: Sorcin and CLIC1

Karaaslan Z., Şengül Yediel B., Şanlı E., Yüceer H., Dursun E., Gezen Ak D., et al.
9th Joint ECTRIMS-ACTRIMS Meeting, Milan, İtalya, 11 - 13 Ekim 2023, cilt.29, sa.3, ss.574-575, (Özet Bildiri)

20. Parenchymal Neuro-Behçet’s Disease or Comorbid Behçet’s Disease with Multiple Sclerosis: A Discriminative Analysis of a Complex Clinical Entity

ISMAYILOV R., GÜNDÜZ T., TALİBOV T., KÜRTÜNCÜ M.
MSMilan2023 9th ECTRIMS-ACTRIMS Meeting, Milan, İtalya, 11 Ekim 2023, cilt.29, ss.137-393, (Özet Bildiri)

21. MS Hasta Serumlarında Bulunan Faktörler In Vitroda Perisit Sağkalımını Etkiler Mi?

Akbayır E., Ulusoy C. A., Yılmaz V., Kürtüncü M., Küçükali C. İ., Tüzün E.
58. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 19 - 24 Kasım 2022, ss.212, (Özet Bildiri)

22. Multipl Skleroz Hastalarında Beyin Omurilik Sıvısı Nörofilament Hafif Zincir Seviyesinin Prognostik Değeri

Demirel A., Şahin E., Gündüz T., Yılmaz V., Tüzün E., Öztürk Erden S., et al.
58. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 19 - 24 Kasım 2022, ss.63, (Özet Bildiri)

23. Otoimmün demiyelinizan santral sinir sistemi hastalıkları ayırıcı tanısında olası biyobelirteçler: Sorcin, CLIC1 ve Src substrate cortactin

Karaaslan Z., Şengül Yediel B., Şanlı E., Yüceer H., Dursun E., Gezen Ak D., et al.
58. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 18 - 24 Kasım 2022, ss.200, (Özet Bildiri)

24. B cell gene expression profile in different demyelinating diseases

Karaaslan Z., Şanlı E., Yüceer H., Timirci Kahraman Ö., Gündüz T., Kürtüncü M., et al.
International Molecular Immunology & Immunogenetics Congress V (MIMIC V), İzmir, Türkiye, 20 - 22 Ekim 2022, (Özet Bildiri)

25. Paraplegia following lumbar puncture: a rare complication of spinal dural arteriovenous fistula

ÇAKAR A., AKÇAY H. İ., GÜNDÜZ T., KÜRTÜNCÜ M.
2nd Congress of European Academy of Neurology, Kopenhag, Danimarka, 28 - 31 Mayıs 2016, (Özet Bildiri)

26. Developing a web-based tele-neurorehabilitation system and implementation in multiple sclerosis patients

Yazgan Y. Z., Vural P., TARAKCI E., ERSÖZ HÜSEYİNSİNOĞLU B., Ormen R., Kapar O. S. K., et al.
38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Hollanda, 26 - 28 Ekim 2022, ss.919-920 identifier

27. Cladribine treatment in turkish MS patients

Gunduz T., Koseoglu M., Ozen P. A., Tutuncu M., Uzunkopru C., Demir S., et al.
38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Hollanda, 26 - 28 Ekim 2022, ss.889-890, (Özet Bildiri) identifier

28. Validity of the Turkish Version of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis

POLAT DÜNYA C., TÜLEK Z., YALÇIN G. Y., GÜNDÜZ T., Panicker J., KÜRTÜNCÜ M., et al.
11th Quadrennial Congress of the European-Association-of-Neuroscience-Nursing (EANN), Manchester, İngiltere, 19 - 22 Mart 2022, (Özet Bildiri)

29. Periferik Kan İmmünfenotiplemesi OSMS'yi NMOSH'den Ayırabilir mi?

KARAASLAN Z., ŞANLI E., YÜCEER H., ULUSOY C. A., KÜÇÜKALİ C. İ., TİMİRCİ KAHRAMAN Ö., et al.
57. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 27 Kasım - 01 Aralık 2021, (Özet Bildiri)

30. Parenkimal Nöro-Behçet Hastalığında Difüzyon Tensor Görüntüleme Bulguları

GÜNDÜZ T., SERVER S., KÜÇÜKALİ C. İ., ÖZYURT O., DEMİR F. G., KÜRTÜNCÜ M.
57. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 27 Kasım - 01 Aralık 2021, (Özet Bildiri)

31. Multipl Skleroz Hastalarında Dimetil Fumarat: Bir Gerçek Yaşam Çalışması

GÜNDÜZ T., Öztürk Erden S., ERAKSOY M., KÜRTÜNCÜ M.
57. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 27 Kasım - 01 Aralık 2021, (Özet Bildiri)

32. İzole Merkezi Sinir Sistemi IgG4 ilişkili Hastalık Tanısında Yeni bir Belirteç: Beyin Omurilik Sıvısı IgG4 İndeksi

BUĞDAYCI Z. G., KİZEK Ö., GÜNDÜZ T., ERAKSOY M., KÜRTÜNCÜ M.
57. Ulusal Nöroloji Kongres, Antalya, Türkiye, 27 Kasım - 01 Aralık 2021, (Özet Bildiri)

33. Can OSMS be differentiated from NMOSD and MS by peripheral blood immunophenotyping?

Şanlı E., Karaaslan Z., Yüceer H., Ulusoy C. A., Küçükali C. İ., Timirci Kahraman Ö., et al.
15th International Society of Neuroimmunology (ISNI) Congress, Nice, Fransa, 8 - 12 Kasım 2021, (Yayınlanmadı)

34. Covid-19 pandemisi döneminde multipl sklerozlu hastaların yaşadıkları psikososyal sorunların değerlendirilmesi

Vızvız G. Y., POLAT DÜNYA C., TÜLEK Z., KÜRTÜNCÜ M.
56.Ulusal Nöroloji Kongresi, Türkiye, 28 Kasım - 02 Aralık 2020, (Özet Bildiri)

35. Multipl Sklerozda Biyobelirteç Olarak Bruch Membran Açıklığı-Minimum Rim Genişliği’nin Değerlendirilmesi

ÖZBİLEN K. T., GÜNDÜZ T., ÇUKUROVA S. N., GEDİK A. C., ERAKSOY M., KÜRTÜNCÜ M.
56. Ulusal Nöroloji Kongresi, Türkiye, 28 Kasım - 02 Aralık 2020, (Özet Bildiri) Sürdürülebilir Kalkınma

36. AN OPEN-LABEL, EXPLORATORY STUDY TO ESTABLISH THE EFFICACY AND SAFETY OF 1-YEAR CANAKINUMAB TREATMENT IN BEHCET'S DISEASE PATIENTS WITH NEUROLOGIC OR VASCULAR INVOLVEMENT

GÜL A., KÜRTÜNCÜ M., Erdugan M., OĞUZ E., GÜNDÜZ T., DEMİR G., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1533-1534, (Özet Bildiri) Creative Commons License identifier

37. A14696G HOMOPLASMIC MUTATION IN THE MITOCHONDRIAL tRNAGlu GENE - CASE REPORT

Dogan F. U., Omerhoca S., Gunduz T., Kurtuncu M., Eraksoy M.
6th Congress of the European-Academy-of-Neurology (EAN), ELECTR NETWORK, 23 - 26 Mayıs 2020, ss.962, (Özet Bildiri) identifier

38. Efficacy of Transcutaneous Posterior Tibial Nerve Stimulation and Pelvic Floor Muscle Training in Female MS Patients with Overactıve Bladder

POLAT C., TÜLEK Z., Panicker J., KÜRTÜNCÜ M.
ECTRIMS-2019, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.345, (Özet Bildiri)

39. Cortical Laminar Necrosis Following the Rapid Correction of Hyponatremia-A Case Report

Tasdemir V., Gunduz T., Kurtuncu M.
Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020, cilt.94, (Özet Bildiri) identifier

40. Progressive Multifocal Leukoencephalopathy Associated with Idiopathic CD4+Lymphocytopenia in a Patient with Heterozygous STAT4 Mutation

Acarli A. N. O., Tuzer C., Gunduz T., Ismayilov R., PARILTAY E., Alpman A., et al.
Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020, cilt.94, (Özet Bildiri) identifier

41. Analysis of Lesion Localization Pattern of Patients with Parenchymal Neuro-Behcet's Disease Using Probability Mapping

Emekli A., Ersozlu E., Gunduz T., Kurtuncu M.
Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020, cilt.94, (Özet Bildiri) identifier

42. Natural Course of Relapsing Tumefactive Multiple Sclerosis and Tumefactive Demyelinating Lesions

Kizek O., Dogan F. U., Gunduz T., Kurtuncu M., Eraksoy M.
Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020, cilt.94, (Özet Bildiri) identifier

43. Recurrent Intracerebral Hemorrhage Due to Alemtuzumab Treatment in a Patient with Multiple Sclerosis: Case Report

Inci M., Gunduz T., Kurtuncu M., Eraksoy M.
Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020, cilt.94, (Özet Bildiri) identifier

44. Doz Azaltarak Kesme Stratejisi Fingolimod Sonrası Rebound Aktivitesini Engeller mi?

GÜNDÜZ T., ISMAYILOV R., KÜRTÜNCÜ M.
55. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 15 - 21 Kasım 2019, (Özet Bildiri)

45. Parenkimal NöroBehçet Hastalığında Lezyon Dağılım Paterninin Olasılık Haritalaması Kullanarak Analizi

EMEKLİ A. S., ERSÖZLÜ E., GÜNDÜZ T., KÜRTÜNCÜ M.
55. Ulusal Nöroloji Kongresi 15 Kasım – 21 Kasım 2019, Antalya, Antalya, Türkiye, 15 - 21 Kasım 2019, (Özet Bildiri)

46. İstanbul Tıp Fakültesi’nin Alemtuzumab Gerçek Yaşam Verisi

AYDOĞAN A., GÜNDÜZ T., KÜRTÜNCÜ M., ERAKSOY M.
55. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 15 Kasım - 21 Eylül 2019, (Özet Bildiri)

47. The Survival of Turkish Patients with Multiple Sclerosis

ŞAMLI S., ŞAHBAZ T., GÜNDÜZ T., UYANIK İ., KÜRTÜNCÜ M.
35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.3-130, (Özet Bildiri)

48. The survival of patients with multiple sclerosis in Turkey

Samli S., Sahbaz T., Gunduz T., Uyanik I., Kurtuncu M.
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, ss.47, (Özet Bildiri) identifier

49. Efficacy of transcutaneous posterior tibial nerve stimulation and pelvic floor muscle training in female MS patients with overactive bladder

Dunya C. P., Tulek Z., Panicker J. N., Kurtuncu M.
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, ss.345, (Özet Bildiri) identifier

50. Comparison of headache characteristics in patients with neuromyelitis optica spectrum disorder and multiple sclerosis

UYGUN Ö., GÜNDÜZ T., KÜRTÜNCÜ M., BAYKAL B.
5th Congress of the European Academy of Neurology, Oslo, Norveç, 29 Haziran - 02 Temmuz 2019, (Özet Bildiri)

51. Submission Group: Describing and understanding functioning; Submitter: Yonca Zenginler Yazgan The effect of fatigue on balance, functionality and body composition in multiple sclerosis

ZENGİNLER YAZGAN Y., Akinci B., GÜNGÖR F., Kurtuncu M., TARAKCI E.
Annual Conference of Rehabilitation in Multiple Sclerosis (RIMS) - Crossing the Interface to Explore New Possibilities, Ljubljana, Slovenya, 20 - 22 Haziran 2019, cilt.25, ss.1069-1070, (Özet Bildiri) identifier

52. Effects of Fingolimod on Cytokine and Chemokine Levels in Patients with Multiple Sclerosis

Kurtuncu M., Yilmaz V., Akcay H. I., Turkoglu R., Altunrende B., Ulusoy C., et al.
71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, Amerika Birleşik Devletleri, 4 - 10 Mayıs 2019, cilt.92, (Özet Bildiri) identifier

53. Long-Term Follow-Up and Results of Patients with MRI Negative Demyelinating Diseases

Kizek O., Ilki C. D., Gunduz T., Kurtuncu M., Eraksoy M.
71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, Amerika Birleşik Devletleri, 4 - 10 Mayıs 2019, cilt.92, (Özet Bildiri) identifier

54. Effects of Fingolimod on Cytokine and Chemokine Levels in Patients with Multiple Sclerosis (P4.2-048)

KÜRTÜNCÜ M., YILMAZ V., AKÇAY H. İ., TÜRKOĞLU R., ALTUNRENDE B., ULUSOY C. A., et al.
71st Annual Meeting of the American-Academy-of-Neurology, Philadelphia, Amerika Birleşik Devletleri, 4 - 10 Mayıs 2019, (Özet Bildiri)

55. TERİFLUNOMİD TEDAVİSİNİN MULTİPL SKLEROZ İLE İLİŞKİLİ ÜVEİT ÜZERİNE ETKİSİ

GÜNDÜZ T., AKSU CEYLAN N., ORAY M., TUTKUN N. İ., KÜRTÜNCÜ M.
NÖRO-OFTALMOLOJİ NÖRO-OTOLOJİ SEMPOZYUMU, Türkiye, 22 - 24 Mart 2019

56. Teriflunomid Tedavisinin Multipl Skleroz ile İlişkili Üveit Üzerine Etkisi

GÜNDÜZ T., AKSU CEYLAN N., ORAY M., TUGAL TUTKUN İ., KÜRTÜNCÜ M.
Nöro-oftalmoloji – Nöro-otoloji sempozyumu 2019, İstanbul, Türkiye, 22 - 24 Mart 2019, (Özet Bildiri)

57. Multiple Sklerozlu Hastalarda “Mesane Semptom Tarama Formu” Geçerlik ve Güvenirlik Çalışması

POLAT DÜNYA C., Vızvız G. Y., TÜLEK Z., KÜRTÜNCÜ M., GÜNDÜZ T., ERAKSOY M.
54. Ulusal Nöroloji Kongresi, Türkiye, 30 Kasım - 06 Aralık 2018, (Özet Bildiri)

58. Fingolimodun Ataklı Yineleyici Multipl Skleroz Hastalarında Sitokin ve Lenfosit Profili Üzerine Etkisi

KÜRTÜNCÜ M., YILMAZ V., AKÇAY H. İ., TÜRKOĞLU R., ALTUNRENDE B., ULUSOY C. A., et al.
54. Ulusal Nöroloji Kongresi, Türkiye, 1 - 05 Aralık 2018, (Tam Metin Bildiri)

59. Plasebo Kontrollü Randomize Multipl Skleroz Çalışmalarında Ortalamaya Dönüş Hatası Yıllar İçinde Artmaktadır

EMEKLİ A. S., ERSÖZLÜ E., GÜNDÜZ T., KÜRTÜNCÜ M.
54. Ulusal Nöroloji kongresi, Türkiye, 30 Kasım - 06 Aralık 2018, (Özet Bildiri)

60. Behçet Hastalığı Zemininde Ortaya Çıkan Kronik İnflamatuar Demiyelinizan Polinöropati Olgusu

DOĞAN F. U., GÜNDÜZ T., PARMAN F. Y., ERAKSOY M., KÜRTÜNCÜ M.
54. Ulusal Nöroloji kongresi, Türkiye, 30 Kasım 2018, (Özet Bildiri)

61. Radyolojik İzole Sendromlu Hastaların Multipl Skleroza Dönüşümünü Öngören Faktörler

ÇİFTÇİ İ., GÜNDÜZ T., KÜRTÜNCÜ M., ERAKSOY M.
54. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 30 Kasım - 06 Aralık 2018, (Özet Bildiri)

62. Nöro-behçet Hastalığı Ne Kadar Süre Tedavi Edilmeli?

GÜNDÜZ T., AYDIN B. N., ALA SELEK S., DEMİR F. G., KÜRTÜNCÜ M.
54. Ulusal Nöroloji Kongresi, Türkiye, 30 Kasım - 06 Aralık 2018, (Özet Bildiri)

63. Çocukluk Yaş Başlangıçlı Demiyelinizan Hastalıklarda Klinik-demografik Özellikler Ve Anti-MOG (Myelin Oligodendrosit Glikoprotein) Antikorlarının Prognoz Üzerindeki Etkilerinin Belirlenmesi

DUMAN İLKİ C., GÜNDÜZ T., TOPALOĞLU P., YAPICI Z., KÜRTÜNCÜ M., ERAKSOY M.
54. Ulusal Nöroloji Kongresi, Türkiye, 30 Kasım - 06 Aralık 2018, (Özet Bildiri)

64. Is placebo effect getting bigger in randomized controlled trials of multiple sclerosis?

Emekli A. S., Ersozlu E., Kurtuncu M., Gunduz T., Eraksoy M.
34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Berlin, Almanya, 10 - 12 Ekim 2018, ss.971-972, (Özet Bildiri) identifier

65. Predictors for conversion of radiologically isolated syndrome to multiple sclerosis

Ciftci I., Gunduz T., Kurtuncu M., Eraksoy M.
34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Berlin, Almanya, 10 - 12 Ekim 2018, ss.760-761, (Özet Bildiri) identifier

66. RLS is an important and frequent cause of depression and anxiety in patients with MS: striking results of the 'RELOMS-T'

Sevim S., Demirkiran M., Terzi M., Yuceyar A. N., Tasdelen B., Idiman E., et al.
34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Berlin, Almanya, 10 - 12 Ekim 2018, ss.174, (Özet Bildiri) identifier

67. Pilot Study Evaluating The Effects Of Transcutaneous Tibial Nerve Stimulation On Urinary Symptoms In Female Patients With Multiple Sclerosis Reporting Overactive Bladder

POLAT C., TÜLEK Z., KÜRTÜNCÜ M., GÜNDÜZ T., Panicker J., ERAKSOY M.
48th Annual Meeting of the International Continence Society, PHILADELPHIA, Amerika Birleşik Devletleri, 28 - 31 Ağustos 2018, (Özet Bildiri)

68. Relatıon Between Edss Bladder Functıonal System Score And Clınıcal Features In Multıple Sclerosıs

POLAT DÜNYA C., KÜRTÜNCÜ M., TÜLEK Z., GÜNDÜZ T., ERAKSOY M.
4th Congress of the European Academy of Neurology, Lisbon, Portekiz, 16 - 19 Haziran 2018, ss.1, (Tam Metin Bildiri)

69. Long-term follow-up of patients with Neuro-Behcet's disease

Kurtuncu M., Gunduz T., Aydin B. N., Emekli A. S., Demir G. A.
4th Congress of the European-Academy-of-Neurology (EAN), Lisbon, Portekiz, 16 - 19 Haziran 2018, ss.355, (Özet Bildiri) identifier

70. Body Composition, Muscle Strength and Physical Activity Level in Multiple Sclerosis and Healthy Population: A pilot study

Zenginler Y., Akinci B., Tarakci E., KURT A., Kurtuncu M.
23rd Annual Conference of Rehabilitation in Multiple Sclerosis (RIMS), Amsterdam, Hollanda, 31 Mayıs - 02 Haziran 2018, cilt.24, ss.879, (Özet Bildiri) identifier

71. A Patient with 4H Syndrome Who Presents in Adulthood

Uygun O., Gunduz T., Kurtuncu M., Eraksoy M.
70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Şili, 21 - 27 Nisan 2018, cilt.90, (Özet Bildiri) identifier

72. Let's raise the awareness of MS specialists concerning the frequency and impact of RLS in MS and consequently the life quality of patients with MS: Striking results of the 'RELOMS-T' Study

Sevim S., Demirkiran M., TERZİ M., Yuceyar N., Tasdelen B., İDİMAN E., et al.
70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Şili, 21 - 27 Nisan 2018, cilt.90, (Özet Bildiri) identifier

73. Multipl sklerozda EDSS- Mesane fonksiyonel durumunun klinik özellikler ile ilişkisi: Retrospektif Çalışma

POLAT C., KÜRTÜNCÜ M., TÜLEK Z., GÜNDÜZ T., ERAKSOY M.
Multiple Skleroz Hemşire Sempozyumu, Gaziantep, Türkiye, 24 - 25 Mart 2018, ss.1, (Tam Metin Bildiri)

74. Aşırı Aktif Mesane Semptomları Bildiren Nörolojik Hastalarda Perkütan Tibial Sinir Uyarısının Cinsel Semptomlar Üzerine Etkisi: Pilot Çalışma

POLAT DÜNYA C., Haslam C., TÜLEK Z., KÜRTÜNCÜ M., Pakzad M., Panicker J.
53. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 24 Kasım 2017, (Özet Bildiri)

75. Alt Üriner Sistem Disfonksiyonu Olan Multipl Sklerozlu Hastalarda Pelvik Taban Kas Egzersizi

POLAT C., TÜLEK Z., KÜRTÜNCÜ M.
53. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 24 - 30 Kasım 2017, (Özet Bildiri)

76. KALITIMSAL NÖROLOJİK HASTALIKLARIN TANISINDA NE KADAR İLERİ GİDİLMELİ? BİR CARASIL AİLESİNİN ANALİZİ

Şahin İ., Sezgin M., Gündüz T., Kürtüncü M.
53. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 24 - 30 Kasım 2017, ss.243, (Özet Bildiri)

77. ALT ÜRİNER SİSTEM DİSFONKSİYONU OLAN MULTİPL SKLEROZLU HASTALARDA PELVİK TABAN KAS EGZERSİZİ

POLAT C., TÜLEK Z., KÜRTÜNCÜ M.
53.ulusal nöroloji kongresi, Antalya, Türkiye, 24 - 30 Kasım 2017, ss.108, (Tam Metin Bildiri)

78. Multipl skleroz gelişiminde aday biyomarkerlarin proteomiks analiz yöntemi ile belirlenmesi

TİMİRCİ KAHRAMAN Ö., KARAASLAN Z., KÜÇÜKALİ C. İ., TÜZÜN E., BAYKAL A. T., KÜRTÜNCÜ M., et al.
53. ulusal nöroloji kongres, Türkiye, 24 - 30 Kasım 2017, (Özet Bildiri)

79. Genetic polymorphism of aquaporin-4 gene in neuromyelitis optica spectrum disorder

Cakar A., Akcay H. I., Ulusoy C., Kucukali C. I., Tuzun E., Gunduz T., et al.
7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, Fransa, 25 - 28 Ekim 2017, ss.692-693, (Özet Bildiri) identifier

80. HoxB3, a novel biomarker that predicts conversion to multiple sclerosis

Tuzun E., Karaaslan Z., Timirci-Kahraman O., Ulusoy C., Kucukali C. I., Gunduz T., et al.
7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, Fransa, 25 - 28 Ekim 2017, ss.428-429, (Özet Bildiri) identifier

81. Neuro-behcet's disease: Analysis of 430 patients

Kurtuncu M., Aydin B. N., Gunduz T., Ala S., Akman-Demir G.
23rd World Congress of Neurology (WCN), Kyoto, Japonya, 16 - 21 Eylül 2017, ss.121-122, (Özet Bildiri) identifier

82. Vascular inflammation markers in multiple sclerosis: possible role in oligoclonal band formation

Turkoglu R., Tuzun E., Kurtuncu M., Eraksoy M.
7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, Fransa, 25 - 28 Ekim 2017, ss.782-783, (Özet Bildiri) identifier

83. Comorbid autoimmunity is not a prognostic factor in multiple sclerosis

Gunduz T., Emekli A. S., Kurtuncu M., Eraksoy M.
7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, Fransa, 25 - 28 Ekim 2017, ss.486, (Özet Bildiri) identifier

84. Disability Progression in Multiple Sclerosis is Biphasic with Uniform Trajectory after Expanded Disability Status Score of Three

UYANIK İ., GÜNDÜZ T., KÜRTÜNCÜ M., ERAKSOY M.
3rd Congress of the European Academy of Neurology, Amsterdam, Hollanda, 24 - 27 Haziran 2017, (Özet Bildiri)

85. Pseudotumor Cerebri Related to Behçet's disease

İBRAHİMOVA G., GÜNDÜZ T., DEMİR F. G., KÜRTÜNCÜ M.
3rd Congress of the European Academy of Neurology, Amsterdam, Hollanda, 24 - 27 Haziran 2017, (Özet Bildiri)

86. Pseudotumor cerebri related to Behcet's disease

Ibrahimova G., Gunduz T., Demir G. A., Kurtuncu M.
3rd Congress of the European-Academy-of-Neurology, Amsterdam, Hollanda, 01 Haziran 2017, ss.283, (Özet Bildiri) identifier

87. Comparison of the Effects of Two Different Balance Systems on the Balance, Functionality and Fatigue of Multiple Sclerosis Patients

Zenginler Y., Tarakci E., TARAKCI D., Kurtuncu M., Ozdincler A. R.
22nd Annual RIMS Conference on Shaping the Future of MS Rehabilitation, Barcelona, İspanya, 4 - 06 Mayıs 2017, cilt.23, ss.895, (Özet Bildiri) identifier

88. Evaluation of Oropharyngeal Dysphagia in Patients With Multiple Sclerosis

Zenginler Y., Tarakci E., Civi T., Kurtuncu M.
22nd Annual RIMS Conference on Shaping the Future of MS Rehabilitation, Barcelona, İspanya, 4 - 06 Mayıs 2017, cilt.23, ss.906-907, (Özet Bildiri) identifier

89. Fingolimod Tedavisinin Multipl Skleroz hastalarında periferik kan hücre immünofenotipleri üzerine etkisi

AKÇAY H. İ., ULUSOY C. A., ÇINAR S., YILMAZ V., Türkoğlu R., Altunrende B., et al.
52. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 25 Kasım - 01 Aralık 2016, ss.30, (Tam Metin Bildiri)

90. Multipl Skleroz Hastalarının Doğum Ayı İle Cinsiyet Arasında Bir İlişki Var mı?

UYANIK İ., GÜNDÜZ T., KÜRTÜNCÜ M., ERAKSOY M.
52. Ulusal Nöroloji Kongresi, Tartışmalı E-poster - 121, Türkiye, 25 Kasım - 01 Aralık 2016, (Özet Bildiri)

91. Worsening of trigeminal neuralgia by dalfampridine in patients with multiple sclerosis

Kurtuncu M., Gunduz T., Oztorun F., Ala S., Eraksoy M.
32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, Kanada, 14 - 17 Eylül 2016, ss.814-815, (Özet Bildiri) identifier

92. Real-life data from efficacy of fingolimod treatment in multiple sclerosis patients in Turkey

Terzi M., Kurtuncu M., Eraksoy M., Karabudak R., Tuncer A., Altunrende B., et al.
32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, Kanada, 14 - 17 Eylül 2016, ss.310, (Özet Bildiri) identifier

93. Multiple sclerosis patients perceive their illness different than neurologists

Kurtuncu M., Uygunoglu U., Tuncer M. A., Kokenli A., Kasap M., Caliskan Z., et al.
32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, Kanada, 14 - 17 Eylül 2016, ss.428, (Özet Bildiri) identifier

94. The impact of Nintendo Wii fit games on the balance and functionality of multiple sclerosis patients: a randomized controlled study

Zenginler Y., Tarakci E., Kurtuncu M., Ozdincler A. R.
32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, Kanada, 14 - 17 Eylül 2016, ss.826, (Özet Bildiri) identifier

95. Comparison of Mitoxantrone versus Cyclophosphamide in Patients with Secondary Progressive Multiple Sclerosis

GÜNDÜZ T., ÖZCAN G., ÇAKAR A., AKÇAY H. İ., ÖZDAĞ ACARLI A. N., KÜRTÜNCÜ M., et al.
2nd Congress of European Academy of Neurology, Kopenhag, Danimarka, 28 - 31 Mayıs 2016, cilt.23, ss.601-879, (Özet Bildiri)

96. Aseptic Meningitis As A Rare Manifestation of Neuro-Behçet’s Disease: Long Term Follow-up of Six Patients

ÖZDAĞ ACARLI A. N., GÜNDÜZ T., ALA SELEK S., DEMİR F. G., KÜRTÜNCÜ M.
2nd Congress of European Academy of Neurology, Kopenhag, Danimarka, 28 - 31 Mayıs 2016, (Özet Bildiri)

97. Detection Of Biomarkers in Cerebrospinal Fluid of Multiple Sclerosis Patients By Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

TİMİRCİ KAHRAMAN Ö., KÜÇÜKALİ C. İ., TÜZÜN E., KÜRTÜNCÜ M., BAYKAL A. T., ERAKSOY M.
X. Annual Congress of the European Proteomics Association, İstanbul, Türkiye, 22 - 25 Haziran 2016, ss.1-2, (Tam Metin Bildiri)

98. Adrenokorti̇kal yetersi̇zli̇kte ön planda akla gelmeyen di̇ğer etyoloji̇ler.

HACİŞAHİNOĞULLARI H., KOÇ M. S., MASTANZADE M., KUBAT ÜZÜM A., GÜNDÜZ T., KARACA M., et al.
38. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Türkiye, 11 Mayıs 2016, (Özet Bildiri)

99. The effect of fingolimod treatment on peripheral blood cell immunophenotypes in patients with multiple sclerosis

ULUSOY C. A., ÇINAR S., YILMAZ V., AKÇAY H. İ., Türkoğlu R., GÜNDÜZ T., et al.
International Molecular Immunology & Immunogenetcs Congress (MIMIC-III), Antalya, Türkiye, 27 - 30 Nisan 2016, cilt.4, ss.75, (Tam Metin Bildiri)

100. Withdrawal Rebound after Fingolimod in Multiple Sclerosis Patients

Gunduz T., Kurtuncu M., Eraksoy M.
68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Kanada, 15 - 21 Nisan 2016, cilt.86, (Özet Bildiri) identifier

101. A Proteomics Approach for the Identification of Cerebrospinal Fluid Proteins Associated with Conversion to Multiple Sclerosis

Kurtuncu M., Turkoglu R., Tuzun E., Kucukali C.
68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Kanada, 15 - 21 Nisan 2016, cilt.86, (Özet Bildiri) identifier

102. Switching From Glatiramer Acetate: Comparison of Disease Modifying Treatments

Kurtuncu M., Akcay H. I., Cakar A., Gunduz T., Tuzun E., Eraksoy M.
ACTRIMS Forum, Louisiana, Amerika Birleşik Devletleri, 18 - 20 Şubat 2016, cilt.22, ss.18-19, (Özet Bildiri) identifier

103. Clinical features of patients with relapsing inflammatory optic neuritis

Tuzun E., Cakar A., Akcay H. I., Kurtuncu M., Eraksoy M.
ACTRIMS Forum, Louisiana, Amerika Birleşik Devletleri, 18 - 20 Şubat 2016, cilt.22, ss.20-21, (Özet Bildiri) identifier

104. Serum prolactin levels in multiple sclerosis, neuromyelitis optica and clinically isolated syndrome patients

Tuzun E., Turkoglu R., Gencer M., Kurtuncu M.
31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, İspanya, 7 - 10 Ekim 2015, ss.716, (Özet Bildiri) identifier

105. The effects of fatigue on balance and quality of life in patients with multiple sclerosis

Ozdincler A., Tarakci E., Zenginler Y., Yeldan I., Kurtuncu M.
31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, İspanya, 7 - 10 Ekim 2015, ss.776, (Özet Bildiri) identifier

106. Comparison of relapse rates after switching from low dose interferon to other disease modifying treatments in patients with multiple sclerosis

MİRA S., ÇOBAN A., KÜRTÜNCÜ M.
1st Congress of the European-Academy-of-Neurology, 20 Haziran 2015

107. Comparison of relapse rates after switching from low dose interferon to other disease modifying treatments in patients with multiple sclerosis

Mira S., Coban A., Kurtuncu M.
1st Congress of the European-Academy-of-Neurology, Berlin, Almanya, 20 - 23 Haziran 2015, ss.662, (Özet Bildiri) identifier

108. Multipl Sklerozda Erken Dönem Serum Sitokin Düzeyleri Değişiminin Uzun Süreli İnterferon Beta1a Kullanım Etkinliği Üzerinde Tahmin Ettirici Rolü Var mıdır

ÇOBAN A., BALCI B., SHUGAİV E., TÜRKOĞLU R., ULUSOY C. A., İÇÖZ S., et al.
49. Ulusal Nöroloji Kongresi, Türkiye, 11 Kasım 2013

109. Reduced serum vitamin D levels in neuromyelitis optica

TÜZÜN E., Küçükhüseyin Ö., KÜRTÜNCÜ M., TURKOGLU R., YAYLIM İ.
EACR Neurological Sciences, İzmir, Türkiye, 25 Nisan 2015, ss.1-2, (Özet Bildiri)

110. Serum antibodies isolated from neuro-Behcet’s disease patients mediate neuronal death and cognitive impairment.

TÜZÜN E., Erdağ E., Şahin C., KÜÇÜKALİ C. İ., KAYA M., KÜRTÜNCÜ M., et al.
AAN 67th Annual Meeting, Vancouver, Kanada, 18 - 25 Nisan 2015, ss.1, (Tam Metin Bildiri)

111. Üveitin Multipl Sklerozun Seyri Üzerine Etkisi

SHUGAİV E., TÜZÜN E., ÇOBAN A., PEHLİVAN M., KÜRTÜNCÜ M., DEMİR G., et al.
49. Ulusal Nöroloji Kongresi, Türkiye, 11 Kasım 2013

112. Uveitis as a prognostic factor in multiple sclerosis

Shugaiv E., TÜZÜN E., ÇOBAN A., Pehlivan M., KÜRTÜNCÜ M., Demir G., et al.
29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS), 02 Ekim 2013

113. Nöromiyelitis Optika ve Otoimmün Ensefalitte Serum Oreksin A düzeyleri

ÇOBAN A., KÜÇÜKALİ C. İ., HAYTURAL H., BENBİR G., ULUSOY C. A., GİRİŞ M., et al.
50. Ulusal Nöroloji Kongresi, Türkiye, 21 Kasım 2014

114. Nöro Behçet Hastalığının Aktif ve İnaktif Dönemlerindeki Gen Ekspresyon Profilleri

UĞUREL E., ŞEHİTOĞLU E., KÜRTÜNCÜ M., TÜZÜN E., SHUGAİV E., ÇOBAN A., et al.
6. DETAE Günleri, Türkiye, 24 Kasım 2014

115. Nöromyelitis Optika ve Otoimmün Ensefalitte Serum Oreksin-A Düzeyleri.

Çoban A., Küçükali C. İ., Haytural H., Benbir Şenel G., Ulusoy C. A., Giriş M., et al.
50. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 21 - 27 Kasım 2014, ss.1, (Tam Metin Bildiri)

116. Manyetik Rezonans İncelemesi Normal Olan Multipl Skleroz Mit mi Gerçek mi

ÇELİK Ş., ÇOBAN A., BİRDAY E., KÜRTÜNCÜ M., ERAKSOY M.
50. Ulusal Nöroloji Kongresi, Türkiye, 21 Kasım 2014

117. Santral Sinir Sistemi Sarkoidozu 10 Hastanın Klinik Seyri

SAMANCI B., ÇELİK Ş., BİLGİÇ B., ÇOBAN A., KÜRTÜNCÜ M., ERAKSOY M.
50. Ulusal Nöroloji Kongresi, Türkiye, 21 Kasım 2014

118. Multipl Skleroz Hastalarının Hastalık Modifiye Edici Tedavilerde Kalma sürelerinin Karşılaştırılması

KÜRTÜNCÜ M., ÇELİK Ş., ÇOBAN A., BİRDAY E., PEHLİVAN M., DEMİR G., et al.
50. Ulusal Nöroloji Kongresi, Türkiye, 21 Kasım 2014

119. Multipl Skleroz Hastalarında Status Epileptikus

AKÇAY H. İ., ÇELİK Ş., ÇOBAN A., KÜRTÜNCÜ M., ERAKSOY M.
50. Ulusal Nöroloji Kongresi, Türkiye, 21 Kasım 2014

120. Psikiyatrik Bulgularla Başlayan Nörobruselloz

AKÇAY H. İ., ÇINAR BALCIOĞLU Ç., ÇELİK Ş., ÇOBAN A., KÜRTÜNCÜ M., ERAKSOY M.
50. Ulusal Nöroloji Kongresi, Türkiye, 21 Kasım 2014

121. Drop out Rate Of Glatiramer Acetate Is Influenced By Body Mass Index In Multiple Sclerosis Patients

KÜRTÜNCÜ M., BALCIOĞLU Ç., ÇELİK Ş., ÇOBAN A., PEHLİVAN M., ERAKSOY M.
7th Congress of the Pan-Asian-Committee-on-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), 06 Kasım 2014

122. Antibodies to DNA repair proteins in HaNDL patients

Erdag E., Tuzun E., Kurtuncu M., Vural B.
12th International Congress of Neuroimmunology (ISNI), Mainz, Almanya, 9 - 13 Kasım 2014, cilt.275, ss.59, (Özet Bildiri) identifier

123. Comparison of dropout rates of disease modifying therapies in multiple sclerosis

KÜRTÜNCÜ M., ÇELİK S., ÇOBAN A., SHUGAİV E., PEHLİVAN M., DEMİR G., et al.
2014 Joint ACTRIMS-ECTRIMS Meeting, 10 Eylül 2014

124. Comparison of dropout rates of disease modifying therapies in multiple sclerosis

Kurtuncu M., Celik S. Y., Coban A., Shugaiv E., Pehlivan M., Akman-Demir G., et al.
Joint ACTRIMS-ECTRIMS Meeting, Massachusetts, Amerika Birleşik Devletleri, 10 - 13 Eylül 2014, ss.198, (Özet Bildiri) identifier

125. Computer assisted cognitive rehabilitation in patients with multiple sclerosis and parenchymal neuro Behçet s disease

NUROVA B., KÜRTÜNCÜ M., ÇOBAN A., BİRDAY E., ERAKSOY M.
EFNS-ENS Joint Congress of European Neurology, 31 Mayıs - 03 Haziran 2014

126. Fingolimod in Relapsing Remitting Multiple Sclerosis: Short Term Safety Profile

Altunrende B., Shugaiv E., Yabalak A., Topcular B., Kocaslan M., Pabuscu E., et al.
6th Congress of the Pan-Asian-Committee-on-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Kyoto, Japonya, 6 - 08 Kasım 2013, cilt.20, ss.928, (Özet Bildiri) identifier

127. Mitochondrial carrier 1 (MTCH1) antibodies in neuromyelitis optica patients with or without aquaporin-4 antibodies

Coban A., Cavus F., Ulusoy C., Turan S., Vural B., Turkoglu R., et al.
6th Congress of the Pan-Asian-Committee-on-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Kyoto, Japonya, 6 - 08 Kasım 2013, cilt.20, ss.942-943, (Özet Bildiri) identifier

128. Cerebral white matter lesions in Behcet's disease: neuro-Behcet's disease or multiple sclerosis?

Akman-Demir G., Mutlu M., Kiyat-Atamer A., Shugaiv E., KÜRTÜNCÜ M., Tugal-Tutkun I., et al.
6th Congress of the Pan-Asian-Committee-on-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Kyoto, Japonya, 6 - 08 Kasım 2013, cilt.20, ss.948-949, (Özet Bildiri) identifier

129. Validity and Reliability of the Turkish Version of Multiple Sclerosis Related Symptom Scale

TÜLEK Z., POLAT C., KÜRTÜNCÜ M., ERAKSOY M.
EFNS Congress (European Federation of Neurological Societies), İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, cilt.678, (Özet Bildiri)

130. Coexistence of neuromyelitis optica and seizures a case report

SHUGAİV E., ÇOBAN A., KÜRTÜNCÜ M., TÜZÜN E., DEMİR G., ERAKSOY M.
EFNS-ENS Joint Congress of European Neurology, 31 Mayıs 2014

131. Gene expression profiles in neuro Behcet s disease during active and inactive stages

UĞUREL E., ŞEHİTOĞLU E., KÜRTÜNCÜ M., SHUGAİV E., ULUSOY C. A., KÜÇÜKERDEN M., et al.
EFNS-ENS Joint Congress of European Neurology, 31 Mayıs 2014

132. Reduced serum orexin levels in antibody positive autoimmune encephalitis and neuromyelitis optica patients.

ULUSOY C. A., Haytural H., KÜÇÜKALİ C. İ., KÜRTÜNCÜ M., Türkoğlu R.
Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, ss.1, (Tam Metin Bildiri)

133. VALIDITY AND RELIABILITY OF THE TURKISH VERSION OF THE MULTIPLE SCLEROSIS-RELATED SYMPTOM SCALE

TÜLEK Z., POLAT C., KÜRTÜNCÜ M., ERAKSOY M.
EFNS-ENS Joint Congress of Neurology, İstanbul, Türkiye, 30 Mayıs - 03 Haziran 2014, ss.1, (Tam Metin Bildiri)

134. Computer assisted cognitive rehabilitation in patients with multiple sclerosis and parenchymal neuro-Behcet's disease

Nurova B., Kurtuncu M., Coban A., Birday E., Eraksoy M.
Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, (Özet Bildiri) identifier

135. Gene expression profiles in neuro-Behcet's disease during active and inactive stages

Ugurel E., Sehitoglu E., KÜRTÜNCÜ M., Shugaiv E., ULUSOY C. A., Kucukerden M., et al.
Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, (Özet Bildiri) identifier

136. Gene expression profiles in neuro-Behcet's disease during active and inactive stages

Ugurel E., Sehitoglu E., Kurtuncu M., Shugaiv E., Ulusoy C., Kucukerden M., et al.
Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, ss.379, (Özet Bildiri) identifier

137. Validity and reliability of the Turkish version of the multiple sclerosis-related symptom scale

Tulek Z., Polat C., Kurtuncu M., Eraksoy M.
Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, ss.678, (Özet Bildiri) identifier

138. Aquaporin 1 antikoru Aquaporin 4 Antikoru pozitif olan ve olmayan Nöromyelitis Optica Hastalarında Yeni Saptanan Bir Antikor

ÇOBAN A., TZARTOS J., STERGİOU C., DEMİR G., ZİSİMOPOULOU P., SHUGAİV E., et al.
49. Ulusal Nöroloji Kongresi, Türkiye, 15 Kasım 2013

139. Aquaporin 1 in Turkish Neuromyelitis Optica Patients with and without Aquaporin 4 Antibodies

ÇOBAN A., Tzartos J., Stergiou C., Demir G., Zisimopoluou P., Shugaiv E., et al.
29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS), 02 Ekim 2013

140. Vibrasyon Duyusu Süresinin Normal Dğerlerinin Saptanması

KARBAY M., PEHLİVAN M., BİRDAY E., ÇOBAN A., KÜRTÜNCÜ M., ERAKSOY M.
49. Ulusal Nöroloji Kongresi, Türkiye, 15 Kasım 2013

141. Karsinomatöz Menenjit Kliniği İle Başvuran Bir Glioblastom Olgusu

ÇAKAR A., KARAASLAN Z., BİRDAY E., ÇOBAN A., KÜRTÜNCÜ M.
49. Ulusal Nöroloji Kongresi, Türkiye, 15 Kasım 2013

142. Natalizumaba Bağlı Progresif Multifokal Lökoensefalopati Olgusu

ÇAKAR A., KARAASLAN Z., KARBAY M., BİRDAY E., ÇOBAN A., PEHLİVAN M., et al.
49. Ulusal Nöroloji Kongresi, Türkiye, 11 Kasım 2013

143. Multipl Sklerozda Bilgisayar Destekli Bilişsel Rehabilitasyonun Etkisi

GÖKÇEİMAM B., BİRDAY E., ÇOBAN A., GÜNDÜZ T., KÜRTÜNCÜ M., ERAKSOY M.
49. Ulusal Nöroloji Kongresi, Türkiye, 11 Kasım 2013

144. Reduction of IL 9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients

KÜRTÜNCÜ M., TÜZÜN E., Balcı B., Birday E., ÇOBAN A., Türkoğlu R., et al.
29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS), 02 Ekim 2013

145. Reduction of IL9 may be an early response marker for interferon β 1a treatment in multiple sclerosis patients

Kurtuncu M., Tuzun E., Petek-Balci B., Birday E., Coban A., Turkoglu R., et al.
29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Copenhagen, Danimarka, 2 - 05 Ekim 2013, ss.450, (Özet Bildiri) identifier

146. Uveitis as a prognostic factor in multiple sclerosis

Shugaiv E., Tuzun E., Coban A., Pehlivan M., Kurtuncu M., Tugal-Tutkun I., et al.
29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Copenhagen, Danimarka, 2 - 05 Ekim 2013, ss.352, (Özet Bildiri) identifier

147. Autoantibodies to aquaporin-1 in Turkish neuromyelitis optica patients with and without aquaporin-4 antibodies

Coban A., Tzartos J., Stergiou C., Akman-Demir G., Zisimopoulou P., Shugaiv E., et al.
29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Copenhagen, Danimarka, 2 - 05 Ekim 2013, ss.85-86, (Özet Bildiri) identifier

148. MTCH1 antibodies in Neuromyelitis Optica patients with or without aquaporin 4 antibodies

ÇOBAN A., Çavuş F., ULUSOY C. A., Turan S., VURAL B., Türkoğlu R., et al.
Twenty-third Meeting of the European Neurological Society, 08 Haziran 2013

149. Arterial CNS Involvement in Behcet's Disease

Akman-Demir G., Birday-Shugaiv E., Kurtuncu M., Mutlu M., Barlas-Yesilot N., Tuzun E., et al.
65th Annual Meeting of the American-Academy-of-Neurology (AAN), California, Amerika Birleşik Devletleri, 16 - 23 Mart 2013, (Özet Bildiri) identifier

150. Uveitis in patients with multiple sclerosis

Shugaiv E., KÜRTÜNCÜ M., Mutlu M., Akman-Demir G., Tugal-Tutkun I., TÜZÜN E., et al.
11th International Congress of Neuroimmunology (ISNI), Massachusetts, Amerika Birleşik Devletleri, 4 - 08 Kasım 2012, ss.34, (Özet Bildiri) identifier

151. White Matter Lesions in Behcet's Disease: Neuro-Behcet's Disease or Multiple Sclerosis?

Akman-Demir G., Mutlu M., Kiyat-Atamer A., Shugaiv E., Kurtuncu M., Tugal-Tutkun I., et al.
64th Annual Meeting of the American-Academy-of-Neurology (AAN), Louisiana, Amerika Birleşik Devletleri, 21 - 28 Nisan 2012, cilt.78, (Özet Bildiri) identifier identifier

152. Elevated Switch-Associated Protein 70 (SWAP70) Antibody Levels during Attacks in Multiple Sclerosis Patients

Erdag E., Ugurel E., Cavus F., Vural B., Kurtuncu M., Eraksoy M., et al.
64th Annual Meeting of the American-Academy-of-Neurology (AAN), Louisiana, Amerika Birleşik Devletleri, 21 - 28 Nisan 2012, cilt.78, (Özet Bildiri) identifier

153. THE INFLUENCE OF CYP2C9 POLYMORPHISM ON ANTICOAGULATION WITH WARFARIN IN PATIENTS WITH CEREBROVASCULAR DISEASE

Atasoy E. B., Celebi A., Hakyemez A., Kaymaz C., KÜRTÜNCÜ M.
15th Congress of the European-Federation-of-Neurological-Societies (EFNS), Budapest, Macaristan, 10 - 13 Eylül 2011, cilt.18, ss.93, (Özet Bildiri) identifier

154. Anti-Neuronal and Stress-Induced-Phosphoprotein 1 Antibodies in Neuro-Behcet's Disease

Akman-Demir G., Vural B., Ugurel E., Icoz S., TÜZÜN E., Kurtuncu M., et al.
63rd AAN Annual Meeting, Hawaii, Amerika Birleşik Devletleri, 9 - 16 Nisan 2011, cilt.76, (Özet Bildiri) identifier

155. Familial effects on the age of onset, initial symptoms and clinical course of multiple sclerosis

ERAKSOY M., DEMİR F. G., YAPICI Z., GÜNDÜZ T., KÜRTÜNCÜ M.
20th Meeting of the European Neurological Society, Berlin, Almanya, 19 - 23 Haziran 2010, cilt.257, ss.1-246, (Özet Bildiri)

156. Familial effects on the age of onset, initial symptoms and clinical courses of multiple sclerosis

Eraksoy M., Akman-Demir G., Yapici Z., Gunduz T., Kurtuncu M.
20th Meeting of the European-Neurological-Society, Berlin, Almanya, 19 - 23 Haziran 2010, (Özet Bildiri) identifier

157. Clinical characteristics of paediatric onset neuro-Behcet's disease

Uluduz D., KÜRTÜNCÜ M., SAİP S., Yapici Z., Akman-Demir G., SİVA A.
20th Meeting of the European-Neurological-Society, Berlin, Almanya, 19 - 23 Haziran 2010, cilt.257 identifier

158. Headache and Neurological Deficits with Cerebrospinal Fluid Lymphocytosis (HaNDL): Could It Be an Autoimmune Disease?

Akman-Demir G., Tuezuen E., KAYA D., Vural B., Ugurel E., Icoez S., et al.
62nd Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 10 - 17 Nisan 2010, (Özet Bildiri) identifier

159. Children (< 10yrs) with clinically isolated syndrome:: long term follow-up for a second clinical event

Eraksoy M., Yapici Z., Akman-Demir G., Kuertuencue M., Oezcan H.
18th Meeting of the European-Neurological-Society, Nice, Fransa, 7 - 11 Haziran 2008, ss.55 identifier

160. Syndrome of transient headache and neurological deficits with cerebrospinal fluid lymphocytosis: is it auto-immune?

KURTUNCU M., TUZUN E., ICOZ S., Baslo B., KAYA D., DURMUS H., et al.
18th Meeting of the European-Neurological-Society, Nice, Fransa, 7 - 11 Haziran 2008, cilt.255, ss.216-217, (Özet Bildiri) identifier

161. Anti-neuronal antibodies in Hashimoto's thyroiditis patients with central nervous system involvement

Durmuş H., Icoez S., Tuezuen E., Kuertuencue M., Hanagasi H. A., Bebek N., et al.
18th Meeting of the European-Neurological-Society, Nice, Fransa, 7 - 11 Haziran 2008, ss.139, (Özet Bildiri) identifier

162. Patients with relapsing-remitting multiple sclerosis with negative brain and spinal MRI for more than 2 years:: a dilemma in diagnosis and treatment approaches

Eraksoy M., Akman-Demir G., Kuertuencue M., Mutlu M., Tuezuen E., Oezcan H.
18th Meeting of the European-Neurological-Society, Nice, Fransa, 7 - 11 Haziran 2008, ss.209-210, (Özet Bildiri) identifier

163. Anti-neuronal antibodies in small-cell lung cancer patients without paraneoplastic disorders

Icoez S., Tuezuen E., Kuertuencue M., Oflazer P., Akman-Demir G.
18th Meeting of the European-Neurological-Society, Nice, Fransa, 7 - 11 Haziran 2008, ss.155, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

164. Clinically unsuspected multiple sclerosis: report of 22 cases and review of the literature

Daksoy M., Kurtuncu M., Akman-Demir G., Yapici Z., Mutlu M., Topcular B., et al.
23rd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/12th Annual Conference of Rehabilitation in MS, Prague, Çek Cumhuriyeti, 11 - 14 Ekim 2007, (Özet Bildiri) identifier

165. Demographic and clinical statistics of multiple sclerosis and demyelinating diseases in an outpatients clinic, Istanbul Faculty of Medicine

Kurtuncu M., Peldivan M., Durmus H., Mutlu M., Yesilot N., Korkmaz F., et al.
23rd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/12th Annual Conference of Rehabilitation in MS, Prague, Çek Cumhuriyeti, 11 - 14 Ekim 2007 identifier

166. Cyclosporine A treatment for ocular involvement of Behcet's disease: is it associated with an increased risk of neurological involvement?

AKMAN-DEMIR G., DEMIR G., AYRANCI O., VANLI E. N., MUTLU M., KURTUNCU M., et al.
17th Meeting of the European-Neurological-Society, Rhodes, Yunanistan, 16 - 20 Haziran 2007, cilt.254, ss.60-61 identifier

167. The use of IFNB-1 b therapy before and after 16 years ofage in children with multiple sclerosis: a prospective follow-up

Eraksoy M., Akinan-Demir G., Yapici Z., Kurtuncu M., Mutlu M., Topcular B., et al.
17th Meeting of the European-Neurological-Society, Rhodes, Yunanistan, 16 - 20 Haziran 2007, ss.39, (Özet Bildiri) identifier

168. Evoked potential studies in parenchymal neuro-Behcet's disease predicting outcome

Akman-Demir G., Oge A. E., Kurtuncu M., Yesilot N., Mutlu M., Boyaciyan A., et al.
17th Meeting of the European-Neurological-Society, Rhodes, Yunanistan, 16 - 20 Haziran 2007, ss.195, (Özet Bildiri) identifier

169. Devic's neuromyelitis optica: a prospective study

Eraksoy M., Akman-Demir G., Kurtuncu M., Yapici Z., Mutlu M., Topcular B., et al.
17th Meeting of the European-Neurological-Society, Rhodes, Yunanistan, 16 - 20 Haziran 2007, ss.36 identifier

170. A patient with zoster myelitis, paraneoplastic severe combined immunodeficiency and paraneoplastic nephrotic syndrome due to malignant invasive thymoma

Kurtuncu M., Ozpeynirci Y., Keles N., Mutlu M., Akman-Demir G., Eraksoy M.
17th Meeting of the European-Neurological-Society, Rhodes, Yunanistan, 16 - 20 Haziran 2007, ss.99, (Özet Bildiri) identifier

171. Probable NMO IgG in Turkish patients with Devic's disease and MS

Akman-Demir G., Demir G., Mutlu M., Icoz S., Kurtuncu M., Yesilor N., et al.
8th International Conference of Neuroimmunology, Nagoya, Japonya, 15 - 19 Ekim 2006, ss.217-218, (Özet Bildiri) identifier

172. Probable NMO IgG in turkish patients with Devic's disease, and multiple sclerosis

Akinan-Demir G., Mutlu M., Icoz S., KÜRTÜNCÜ M., Yesilot N., Eraksoy M.
22nd Congress of the European-Committee-for-the-Treatment-and-Resarch-in-Multiple-Sclerosis, Madrid, İspanya, 27 - 30 Eylül 2006, cilt.12, (Özet Bildiri) identifier

173. Is a 10-year follow-up enough to predict to subsequent disability rate in multiple sclerosis?

Mutlu M., Ceylan H., Akman-Demir G., KÜRTÜNCÜ M., Eraksoy M.
22nd Congress of the European-Committee-for-the-Treatment-and-Resarch-in-Multiple-Sclerosis, Madrid, İspanya, 27 - 30 Eylül 2006, cilt.12, (Özet Bildiri) identifier

174. Conversion to definite multiple sclerosis in Turkish patients with clinically isolated syndromes

Mutlu M., Akman-Demir G., KÜRTÜNCÜ M., Eraksoy M.
22nd Congress of the European-Committee-for-the-Treatment-and-Resarch-in-Multiple-Sclerosis, Madrid, İspanya, 27 - 30 Eylül 2006, cilt.12, (Özet Bildiri) identifier

175. CNS consequences of 5-lipoxygenase inhibition/deficiency

Manev R., Imbesi M., Zavoreo I., KÜRTÜNCÜ M., Uz T., Dimitrijevic N., et al.
25th CINP Congress, Illinois, Amerika Birleşik Devletleri, 9 - 13 Temmuz 2006, cilt.9, (Özet Bildiri) identifier

176. Neurosyphilis presenting status epilepticus: Two HIV (-) patients with EEG features

Gurses C., Kurtuncu M., Yesilot N., Hanagasi H. A., Bebek N., Baykan B., et al.
18th World Congress of Neurology, Sydney, Avustralya, 5 - 11 Kasım 2005, cilt.238, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

177. Two HIV (-) patients with neurosyphilis presenting convulsive and nonconvulsive status epilepticus in different stages of their disease

GURSES C., KURTUNCU M., Yesilot N., HANAGASI H. A., BEBEK N., BAYKAN B., et al.
26th International Epilepsy Congress, Paris, Fransa, 28 Ağustos - 01 Eylül 2005, cilt.46, ss.147, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

178. Malignant lymphoma and chronic inflammatory demyelinating polyneuropathy: a case report

Çoban A., Kürtüncü M., Gürer R., Işık N., Serdaroğlu P., Deymeer F., et al.
7th International Congress of Mediterranean Society of Myology, Aydın, Türkiye, 27 - 30 Mayıs 2004, cilt.23, sa.12, ss.51, (Özet Bildiri)
Kitaplar 4

1. Gen Çevresel Faktörler Etkileşimi - Epigenetik Faktörler

EMEKLİ A. S., KÜRTÜNCÜ M.
Multipl skleroz ve kadın, Ayşe Nur Yüceyar, Rana Karabudak, Hüsnü Efendi, Editör, Bilmedya Yayınevi, İstanbul, ss.9-16, 2023

2. Primer merkezi sinir sistemi vasküliti

EMEKLİ A. S., KÜRTÜNCÜ M.
Nöroimmünoloji, Canan Yücesan, Aslı Tuncer, Cihat Uzunköprü, Editör, Nobel Tıp Kitabevi, İstanbul, ss.277-292, 2023

3. Neuro-Behçet’s Disease

Tüzün E. (Editör), Kürtüncü M. (Editör)
Springer, London/Berlin , London, 2021

4. Preface

Tüzün E., Kürtüncü M.
Neuro-Behçet's Disease: Pathogenesis, Clinical Aspects, Treatment, Erdem Tüzün,Murat Kürtüncü, Editör, Springer-Verlag , London, 2021
Diğer Yayınlar 1

1. Multipl Skleroz Gelişiminde Aday Biyomarkerların Proteomiks Analiz Yöntemi ile Belirlenmesi

TİMİRCİ KAHRAMAN Ö., KÜÇÜKALİ C. İ., KARAASLAN Z., TÜZÜN E., BAYKAL A. T., KÜRTÜNCÜ M., et al.
Sunum, ss.1-2, 2017
Metrikler

Yayın

387

Yayın (WoS)

279

Yayın (Scopus)

191

Atıf (WoS)

2282

H-İndeks (WoS)

25

Atıf (Scopus)

2221

H-İndeks (Scopus)

26

Atıf (TrDizin)

5

H-İndeks (TrDizin)

1

Proje

19

Tez Danışmanlığı

4

Açık Erişim

19
BM Sürdürülebilir Kalkınma Amaçları